Ligand source activities (1 row/activity)



Get vendors


Ligands Receptor Assay information Chemical information
Sel. page Common
name		 GPCRdb ID #Vendors Reference
ligand		 Fold selectivity
(Potency)		 # tested GPCRs
(Potency)		 Species p-value
(-log)		 Type Activity
Relation		 Activity
Value		 Assay Type Assay Description Source Mol
weight		 Rot
Bonds		 H don H acc LogP Smiles DOI
2924 1610 37 None -10 6 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
44398069 1610 37 None -10 6 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
9908268 1610 37 None -10 6 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
CHEMBL114606 1610 37 None -10 6 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
11452022 3539 33 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
6996 3539 33 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
CHEMBL366208 3539 33 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
25192005 7654 0 None -3 2 Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1089004 7654 0 None -3 2 Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
44406004 72370 8 None 5 4 Human 9.8 pEC50 = 9.8 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 337 14 4 4 2.9 CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL199791 72370 8 None 5 4 Human 9.8 pEC50 = 9.8 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 337 14 4 4 2.9 CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
25192001 7976 0 None -2 4 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 7976 0 None -2 4 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
46884020 8355 0 None -30 4 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1093686 8355 0 None -30 4 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
10883396 3592 39 None 1 14 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
5283560 3592 39 None 1 14 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
911 3592 39 None 1 14 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
CHEMBL225155 3592 39 None 1 14 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
10883396 3592 39 None 1 14 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
5283560 3592 39 None 1 14 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
911 3592 39 None 1 14 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
CHEMBL225155 3592 39 None 1 14 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
76332615 105075 0 None 5 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 12 3 8 5.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(CC)(CC)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121986 105075 0 None 5 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 12 3 8 5.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(CC)(CC)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
44565714 178717 0 None -6 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473238 178717 0 None -6 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
2924 1610 37 None -10 6 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
44398069 1610 37 None -10 6 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
9908268 1610 37 None -10 6 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
CHEMBL114606 1610 37 None -10 6 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
44218130 139360 0 None -1 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 14 3 8 4.3 CCc1cc(-c2noc(-c3cc(CN(C)CC(C)C)cc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799355 139360 0 None -1 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 14 3 8 4.3 CCc1cc(-c2noc(-c3cc(CN(C)CC(C)C)cc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
10883396 3592 39 None 1 14 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
5283560 3592 39 None 1 14 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
911 3592 39 None 1 14 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
CHEMBL225155 3592 39 None 1 14 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
11222939 67233 6 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
44438254 67233 6 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
CHEMBL190006 67233 6 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
44591250 189162 0 None -19 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL515921 189162 0 None -19 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
44591266 178720 0 None -19 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL473269 178720 0 None -19 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
44422606 85147 0 None -2 5 Human 7.0 pEC50 = 7 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 329 11 3 3 3.1 CCCCCCc1ccc(OC[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL228049 85147 0 None -2 5 Human 7.0 pEC50 = 7 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 329 11 3 3 3.1 CCCCCCc1ccc(OC[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
44219525 139412 0 None -47 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799686 139412 0 None -47 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44218450 139419 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)CC 10.1016/j.ejmech.2016.03.048
CHEMBL3799718 139419 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)CC 10.1016/j.ejmech.2016.03.048
76325739 105589 0 None -11 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 462 11 4 7 3.4 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133595 105589 0 None -11 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 462 11 4 7 3.4 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76336567 105597 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 432 9 4 6 3.0 Cc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133602 105597 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 432 9 4 6 3.0 Cc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76311231 105598 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133603 105598 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3780292 105598 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76332957 105605 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2c(CCC(N)(CO)COP(=O)(O)O)cccc2c1 10.1039/C3MD00079F
CHEMBL3133610 105605 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2c(CCC(N)(CO)COP(=O)(O)O)cccc2c1 10.1039/C3MD00079F
45377937 83704 0 None -112 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 496 9 1 6 5.1 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)CC3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207780 83704 0 None -112 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 496 9 1 6 5.1 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)CC3)cc2)s1 10.1016/j.bmcl.2012.09.110
66655587 167075 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4205714 167075 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4301563 167075 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
46846906 139511 0 None -2290 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
CHEMBL3800257 139511 0 None -2290 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
70692256 74625 0 None -3162 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 468 8 1 4 6.1 CN(CCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1)CC(=O)O 10.1016/j.bmcl.2012.04.095
CHEMBL2032429 74625 0 None -3162 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 468 8 1 4 6.1 CN(CCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1)CC(=O)O 10.1016/j.bmcl.2012.04.095
70694327 74630 0 None -12589 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.8 O=C(O)CCN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032434 74630 0 None -12589 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.8 O=C(O)CCN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
11853835 104233 0 None -501 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 10 2 6 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm4014373
CHEMBL3105482 104233 0 None -501 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 10 2 6 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm4014373
46237828 8858 0 None -5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 369 4 1 6 3.4 COc1cc(/C=C2\S/C(=N\N(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1098013 8858 0 None -5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 369 4 1 6 3.4 COc1cc(/C=C2\S/C(=N\N(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
57398845 70575 0 None -1548 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 489 9 1 7 5.9 CCc1ccccc1Oc1ccc(-c2nc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)no2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951313 70575 0 None -1548 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 489 9 1 7 5.9 CCc1ccccc1Oc1ccc(-c2nc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)no2)cc1 10.1016/j.bmcl.2011.12.019
42636433 115892 0 None -1258 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 455 7 1 6 4.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)CC4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359846 115892 0 None -1258 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 455 7 1 6 4.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)CC4)no2)cc1Cl 10.1021/jm5010336
44125704 115900 0 None -316 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359854 115900 0 None -316 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
25182769 6188 0 None -4073 3 Human 4.0 pEC50 = 4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 380 6 2 5 4.3 Cc1cc(O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1081645 6188 0 None -4073 3 Human 4.0 pEC50 = 4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 380 6 2 5 4.3 Cc1cc(O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
53319457 57092 0 None -69 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4nc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651851 57092 0 None -69 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4nc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
118716139 114374 0 None -79 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 6 3.0 Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341917 114374 0 None -79 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 6 3.0 Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
46236933 8966 0 None 7 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2cccc(O)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098771 8966 0 None 7 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2cccc(O)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
16736755 57061 0 None -64 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 413 8 1 4 5.4 CCCCOc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3Cl)cc2c1 10.1021/ml100227q
CHEMBL1651714 57061 0 None -64 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 413 8 1 4 5.4 CCCCOc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3Cl)cc2c1 10.1021/ml100227q
11853576 104241 0 None -204 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 441 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNCCO 10.1021/jm4014373
CHEMBL3105490 104241 0 None -204 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 441 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNCCO 10.1021/jm4014373
11224984 8629 18 None -44 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 8629 18 None -44 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
46236811 8887 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1 10.1021/jm100181s
CHEMBL1098201 8887 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1 10.1021/jm100181s
76325533 105288 0 None -537 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126613 105288 0 None -537 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
72793789 103917 0 None -380 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 1 5 5.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN1CC(C(=O)O)C1 10.1021/jm4014373
CHEMBL3102986 103917 0 None -380 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 1 5 5.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN1CC(C(=O)O)C1 10.1021/jm4014373
11363176 3100 42 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
5446 3100 42 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
9320 3100 42 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096146 3100 42 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
25182926 7859 0 None -173 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 451 11 3 6 3.8 O=C(O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 10.1016/j.bmcl.2010.01.102
CHEMBL1090423 7859 0 None -173 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 451 11 3 6 3.8 O=C(O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 10.1016/j.bmcl.2010.01.102
11852144 105096 0 None -323 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@H](O)CO 10.1021/jm401456d
CHEMBL3122006 105096 0 None -323 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@H](O)CO 10.1021/jm401456d
76318056 105063 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 541 11 3 8 4.7 CCCc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121974 105063 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 541 11 3 8 4.7 CCCc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c2c1CC(C)(C)CC2 10.1021/jm401456d
76321772 105077 0 None -2 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 553 10 3 8 4.8 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CCCC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121988 105077 0 None -2 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 553 10 3 8 4.8 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CCCC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
11689680 79230 0 None -3890 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL211505 79230 0 None -3890 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.064
24825338 77357 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208924 77357 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.04.084
72793828 104214 0 None -109 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 439 6 2 6 5.0 Cc1cc(-c2cnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
CHEMBL3105250 104214 0 None -109 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 439 6 2 6 5.0 Cc1cc(-c2cnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
127046185 139487 0 None -363 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800120 139487 0 None -363 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
24825338 77357 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL208924 77357 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
1160618 30591 1 None 2 2 Human 7.0 pEC50 = 7.0 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 389 6 0 6 4.9 O=C(CSc1nnc(-c2ccco2)o1)N(C1CCCCC1)C1CCCCC1 nan
CHEMBL1396471 30591 1 None 2 2 Human 7.0 pEC50 = 7.0 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 389 6 0 6 4.9 O=C(CSc1nnc(-c2ccco2)o1)N(C1CCCCC1)C1CCCCC1 nan
44412883 76944 0 None -77 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 404 7 1 4 6.2 Cc1cc(CCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208224 76944 0 None -77 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 404 7 1 4 6.2 Cc1cc(CCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
11689680 79230 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL211505 79230 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
70686051 74923 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 466 4 2 4 5.2 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(C(=O)O)c21 10.1021/ml200252b
CHEMBL2037123 74923 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 466 4 2 4 5.2 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(C(=O)O)c21 10.1021/ml200252b
44625752 87165 0 None -2754 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 554 10 2 4 7.0 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Br)c1 10.1021/ml300396r
CHEMBL2336066 87165 0 None -2754 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 554 10 2 4 7.0 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Br)c1 10.1021/ml300396r
11689680 79230 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL211505 79230 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
57393585 70577 0 None -2454 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 503 9 1 7 6.5 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C(C)C)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951315 70577 0 None -2454 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 503 9 1 7 6.5 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C(C)C)cc2)n1 10.1016/j.bmcl.2011.12.019
57395264 71316 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935583 71316 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963633 71316 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
53234382 147856 0 None -457 2 Human 5.0 pEC50 = 5.0 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 431 8 2 6 4.3 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CNCCC(=O)O)ccc2-3)cc1C#N nan
CHEMBL3937499 147856 0 None -457 2 Human 5.0 pEC50 = 5.0 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 431 8 2 6 4.3 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CNCCC(=O)O)ccc2-3)cc1C#N nan
24850258 57685 0 None 2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4cc(Cc5ccccc5)ccc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672553 57685 0 None 2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4cc(Cc5ccccc5)ccc4n3)c(F)c2)C1 10.1021/ml100228m
118716140 114375 0 None -147 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 7 2.7 COc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341918 114375 0 None -147 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 7 2.7 COc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
76325531 105277 0 None -1584 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126602 105277 0 None -1584 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
76332955 105591 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 461 11 5 6 3.2 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c[nH]1 10.1039/C3MD00079F
CHEMBL3133597 105591 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 461 11 5 6 3.2 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c[nH]1 10.1039/C3MD00079F
76336566 105590 0 None -56 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 474 11 4 7 3.7 NC(CO)(CCc1ccc(Oc2ccc(-c3coc(C4CC4)n3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133596 105590 0 None -56 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 474 11 4 7 3.7 NC(CO)(CCc1ccc(Oc2ccc(-c3coc(C4CC4)n3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
57396084 70354 0 None -2238 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950569 70354 0 None -2238 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
11315069 8834 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097801 8834 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46237178 8836 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 423 8 0 5 4.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCCN(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097803 8836 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 423 8 0 5 4.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCCN(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236270 8922 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 370 3 1 4 4.7 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098449 8922 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 370 3 1 4 4.7 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CC2)N1c1ccccc1 10.1021/jm100181s
76325748 105611 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 475 11 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(F)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133704 105611 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 475 11 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(F)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
66636757 105061 0 None -1288 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 445 10 3 8 2.9 CCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121971 105061 0 None -1288 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 445 10 3 8 2.9 CCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
25182900 152473 0 None -60 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 401 6 1 5 4.8 O=C(Nc1ccnc2ccccc12)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL3975495 152473 0 None -60 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 401 6 1 5 4.8 O=C(Nc1ccnc2ccccc12)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
44565738 189161 0 None -19 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL515917 189161 0 None -19 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
46236398 8475 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 7 1 4 5.3 CCCCCCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094502 8475 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 7 1 4 5.3 CCCCCCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
2924 1610 37 None -10 6 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
44398069 1610 37 None -10 6 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
9908268 1610 37 None -10 6 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
CHEMBL114606 1610 37 None -10 6 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
44565596 188955 0 None -104 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514302 188955 0 None -104 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
24956673 8434 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 3 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094192 8434 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 3 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
42622931 139147 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 3 9 3.3 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3797940 139147 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 3 9 3.3 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
66829308 139563 0 None -169 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.7 CCCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3800591 139563 0 None -169 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.7 CCCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
11540052 179985 0 None -33 4 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL475405 179985 0 None -33 4 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
11624780 77588 0 None -354 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 365 7 1 5 4.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(CC(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209566 77588 0 None -354 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 365 7 1 5 4.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(CC(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
11360553 58141 0 None -26 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 365 9 1 3 4.3 O=C(O)CCN1CC=C(c2ccc(OCCCc3ccccc3)cc2)CC1 10.1016/j.bmcl.2011.01.029
CHEMBL1683049 58141 0 None -26 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 365 9 1 3 4.3 O=C(O)CCN1CC=C(c2ccc(OCCCc3ccccc3)cc2)CC1 10.1016/j.bmcl.2011.01.029
53324339 57693 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672561 57693 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
127046096 139075 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797452 139075 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
56949137 150059 0 None -8 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c(F)c1 nan
CHEMBL3955131 150059 0 None -8 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c(F)c1 nan
57391457 70558 0 None -109 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccc(Oc2ccc(-c3nc(-c4csc(CN5CC(C(=O)O)C5)c4)no3)cc2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951155 70558 0 None -109 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccc(Oc2ccc(-c3nc(-c4csc(CN5CC(C(=O)O)C5)c4)no3)cc2)cc1 10.1016/j.bmcl.2011.12.019
118707197 112545 0 None -5248 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 13 3 5 4.1 CCc1cc(C(=O)CCCc2ccc(C)cc2)ccc1COC[C@@](C)(N)COP(=O)(O)O 10.1016/j.bmc.2014.05.035
CHEMBL3311352 112545 0 None -5248 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 13 3 5 4.1 CCc1cc(C(=O)CCCc2ccc(C)cc2)ccc1COC[C@@](C)(N)COP(=O)(O)O 10.1016/j.bmc.2014.05.035
46846901 139564 0 None -7585 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 430 7 1 7 4.1 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3800595 139564 0 None -7585 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 430 7 1 7 4.1 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
53318124 57091 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1651850 57091 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
53318124 57091 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651850 57091 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
53318124 57091 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651850 57091 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
118716182 114403 0 None -81 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 8 2.6 NC(CO)(CCc1ccc(-c2cn(-c3ccc(OC(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342007 114403 0 None -81 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 8 2.6 NC(CO)(CCc1ccc(-c2cn(-c3ccc(OC(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11852955 105090 0 None -81 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 9 3 8 4.0 CCc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3122000 105090 0 None -81 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 9 3 8 4.0 CCc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
44412827 77388 0 None -102 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 432 9 1 4 6.9 Cc1cc(CCCCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209008 77388 0 None -102 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 432 9 1 4 6.9 Cc1cc(CCCCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
46238366 8728 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 358 3 1 4 4.5 CC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096788 8728 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 358 3 1 4 4.5 CC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
11224984 8629 18 None -44 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 8629 18 None -44 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
44439850 145494 0 None -588 3 Human 6.9 pEC50 = 6.9 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 446 6 1 5 5.7 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391870 145494 0 None -588 3 Human 6.9 pEC50 = 6.9 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 446 6 1 5 5.7 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
76318197 105284 0 None -53 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cnc(N4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126609 105284 0 None -53 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cnc(N4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46237179 8740 0 None -11 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 430 7 1 5 4.9 CCC/N=C1\S/C(=C\c2ccc(OCCO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096873 8740 0 None -11 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 430 7 1 5 4.9 CCC/N=C1\S/C(=C\c2ccc(OCCO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
46236400 8473 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 6 1 6 3.7 CCOC(=O)CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094491 8473 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 6 1 6 3.7 CCOC(=O)CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
44199424 105292 0 None -251 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126617 105292 0 None -251 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
70690096 74637 0 None -1258 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 7 1 4 6.1 O=C(O)C1CN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032441 74637 0 None -1258 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 7 1 4 6.1 O=C(O)C1CN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44219369 139424 0 None -346 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799748 139424 0 None -346 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
66636736 105060 0 None -269 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 11 3 8 3.3 CCCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121970 105060 0 None -269 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 11 3 8 3.3 CCCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
66655198 163108 0 None -79 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 449 7 1 4 5.2 O=C(O)CCCN1CCC2(CC1)COc1cc(OCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4204437 163108 0 None -79 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 449 7 1 4 5.2 O=C(O)CCCN1CCC2(CC1)COc1cc(OCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
70694326 74628 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.9 O=C(O)CC1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032432 74628 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.9 O=C(O)CC1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
44129373 115895 0 None -2511 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 418 6 2 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359849 115895 0 None -2511 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 418 6 2 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1C#N 10.1021/jm5010336
11852437 105066 0 None -316 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 444 9 2 5 5.0 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121977 105066 0 None -316 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 444 9 2 5 5.0 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
46236662 8685 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
CHEMBL1096478 8685 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
73333750 105588 0 None -31 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 448 10 4 7 3.2 Cc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133594 105588 0 None -31 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 448 10 4 7 3.2 Cc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
46236271 8924 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 384 3 1 4 5.1 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098450 8924 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 384 3 1 4 5.1 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCC2)N1c1ccccc1 10.1021/jm100181s
24957028 8840 0 None -3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccc(Cl)c1 10.1021/jm100181s
CHEMBL1097808 8840 0 None -3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccc(Cl)c1 10.1021/jm100181s
45255648 148381 0 None -19 2 Human 6.9 pEC50 = 6.9 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCC nan
CHEMBL3941765 148381 0 None -19 2 Human 6.9 pEC50 = 6.9 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCC nan
46205774 7835 0 None -8 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 491 11 4 5 4.3 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2)cc1Cl)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1090223 7835 0 None -8 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 491 11 4 5 4.3 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2)cc1Cl)COP(=O)(O)O 10.1021/jm901776q
76336568 105530 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 407 11 4 4 2.8 CCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3132869 105530 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 407 11 4 4 2.8 CCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46846912 139273 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 478 7 1 7 5.2 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4-c4ccccc4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3798784 139273 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 478 7 1 7 5.2 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4-c4ccccc4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
70688177 74931 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 495 6 2 5 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnc(CCC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037131 74931 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 495 6 2 5 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnc(CCC(=O)O)cc21 10.1021/ml200252b
58537228 139415 0 None -2951 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3799693 139415 0 None -2951 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
57570486 87168 0 None -3235 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 11 2 4 7.1 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C2CC2)c1 10.1021/ml300396r
CHEMBL2336069 87168 0 None -3235 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 11 2 4 7.1 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C2CC2)c1 10.1021/ml300396r
56949017 144255 0 None 2 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 480 7 0 5 7.1 Clc1ncn(Cc2cccc(-c3noc(CCC4(c5ccccc5)CCCCC4)n3)c2)c1Cl nan
CHEMBL3909228 144255 0 None 2 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 480 7 0 5 7.1 Clc1ncn(Cc2cccc(-c3noc(CCC4(c5ccccc5)CCCCC4)n3)c2)c1Cl nan
53235407 148962 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2noc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
CHEMBL3946363 148962 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2noc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
57395297 70567 0 None -426 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 9 1 7 5.7 CCCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951305 70567 0 None -426 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 9 1 7 5.7 CCCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
46881538 7245 0 None -66 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 529 12 3 7 3.7 Cc1cc(S(=O)(=O)NCCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1086158 7245 0 None -66 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 529 12 3 7 3.7 Cc1cc(S(=O)(=O)NCCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
44599024 57103 0 None -10 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 473 6 1 5 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651862 57103 0 None -10 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 473 6 1 5 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
76321895 105282 0 None -13489 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126607 105282 0 None -13489 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46224715 197578 0 None -123 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 371 3 1 5 2.5 Cc1nn(C(=O)/C=C/c2cccc(S(N)(=O)=O)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL590135 197578 0 None -123 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 371 3 1 5 2.5 Cc1nn(C(=O)/C=C/c2cccc(S(N)(=O)=O)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
11553524 103920 0 None -741 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 418 7 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(Cl)c1OCCO 10.1021/jm4014373
CHEMBL3102989 103920 0 None -741 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 418 7 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(Cl)c1OCCO 10.1021/jm4014373
46236931 8930 0 None 7 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 0 3 5.3 CC(C)/N=C1\S/C(=C\c2ccc(Br)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098484 8930 0 None 7 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 0 3 5.3 CC(C)/N=C1\S/C(=C\c2ccc(Br)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236929 8888 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 5 0 5 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1OC 10.1021/jm100181s
CHEMBL1098202 8888 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 5 0 5 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1OC 10.1021/jm100181s
118716177 114398 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 7 2.0 Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342002 114398 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 7 2.0 Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
24956675 8549 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1095152 8549 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
44217839 105293 0 None -107 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(CC(C)C)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126618 105293 0 None -107 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(CC(C)C)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
118716186 114407 0 None -5 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 8 1.5 N#Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342011 114407 0 None -5 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 8 1.5 N#Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
118716155 114392 0 None -3 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 500 10 4 6 3.7 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341933 114392 0 None -3 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 500 10 4 6 3.7 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
44591265 179401 0 None -23 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL474689 179401 0 None -23 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
46238363 8726 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.0 CN(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096786 8726 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.0 CN(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
127046549 139530 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(OC4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800402 139530 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(OC4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11852143 105095 0 None -549 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CO 10.1021/jm401456d
CHEMBL3122005 105095 0 None -549 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CO 10.1021/jm401456d
67266022 139534 0 None -70 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 4 9 3.2 CCc1cc(-c2noc(-c3cc(C)c(CNCC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800430 139534 0 None -70 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 4 9 3.2 CCc1cc(-c2noc(-c3cc(C)c(CNCC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44217997 139054 0 None -933 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(OC)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797365 139054 0 None -933 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(OC)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
127046568 139057 0 None -128 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(OC4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797376 139057 0 None -128 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(OC4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
57391821 71315 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935581 71315 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963632 71315 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
57437353 105084 0 None -234 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 515 12 3 6 4.4 CCc1cc(CCC(=O)c2sc(CC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121995 105084 0 None -234 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 515 12 3 6 4.4 CCc1cc(CCC(=O)c2sc(CC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46237176 8775 0 None 6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OC(CO)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097183 8775 0 None 6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OC(CO)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236523 8874 0 None -3 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1Cl 10.1021/jm100181s
CHEMBL1098143 8874 0 None -3 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1Cl 10.1021/jm100181s
57397897 70351 0 None -724 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 4.8 O=C(O)CNCCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950566 70351 0 None -724 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 4.8 O=C(O)CNCCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
16737345 57054 0 None -1 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 390 5 1 4 4.6 O=C(O)C1CN(Cc2ccc(-c3cc4cc(N5CCCCC5)ccc4o3)cc2)C1 10.1021/ml100227q
CHEMBL1651708 57054 0 None -1 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 390 5 1 4 4.6 O=C(O)C1CN(Cc2ccc(-c3cc4cc(N5CCCCC5)ccc4o3)cc2)C1 10.1021/ml100227q
66829311 139279 0 None -288 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798837 139279 0 None -288 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
67170110 143232 0 None -7079 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 499 4 1 6 5.4 O=C(O)C1CN(c2cc3c(cc2F)-c2noc(-c4onc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 nan
CHEMBL3900885 143232 0 None -7079 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 499 4 1 6 5.4 O=C(O)C1CN(c2cc3c(cc2F)-c2noc(-c4onc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 nan
76332741 105262 0 None -147 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 10 3 8 3.9 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126586 105262 0 None -147 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 10 3 8 3.9 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76321770 104956 0 None -6 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.4 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](C)CO 10.1021/jm401456d
CHEMBL3120183 104956 0 None -6 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.4 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](C)CO 10.1021/jm401456d
76336212 105054 0 None -9 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 8 3 8 3.8 Cc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121964 105054 0 None -9 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 8 3 8 3.8 Cc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
66829279 139064 0 None -117 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797412 139064 0 None -117 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11603726 76477 0 None -6760 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL206940 76477 0 None -6760 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
57391920 69543 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/ml200252b
CHEMBL1938937 69543 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/ml200252b
57391920 69543 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938937 69543 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57570498 87184 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 4 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336086 87184 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 4 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
127048143 139317 0 None -354 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 14 3 9 3.1 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
CHEMBL3799148 139317 0 None -354 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 14 3 9 3.1 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
127046566 139467 0 None -338 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799976 139467 0 None -338 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
53235479 150029 0 None -1737 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 475 6 1 6 4.8 CC(C)Cc1onc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c1C(F)(F)F nan
CHEMBL3954922 150029 0 None -1737 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 475 6 1 6 4.8 CC(C)Cc1onc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c1C(F)(F)F nan
44422590 85104 0 None -12 2 Human 4.8 pEC50 = 4.8 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227530 85104 0 None -12 2 Human 4.8 pEC50 = 4.8 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
57397066 70568 0 None -199 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.9 CC(C)c1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951306 70568 0 None -199 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.9 CC(C)c1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
11978048 70573 0 None -3801 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 9 1 8 5.3 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3OC)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951311 70573 0 None -3801 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 9 1 8 5.3 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3OC)cc2)n1 10.1016/j.bmcl.2011.12.019
46881875 7249 0 None -7 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 371 13 3 3 4.3 CCCCCCCOc1ccc(CC[C@](C)(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1086170 7249 0 None -7 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 371 13 3 3 4.3 CCCCCCCOc1ccc(CC[C@](C)(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
25031771 105255 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126434 105255 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
44218002 105286 0 None -776 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)c(CC(C)C)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126611 105286 0 None -776 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)c(CC(C)C)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
118716157 114394 0 None -23 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 6 2.8 CCCCCc1nc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)co1 10.1016/j.ejmech.2014.07.081
CHEMBL3341935 114394 0 None -23 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 6 2.8 CCCCCc1nc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)co1 10.1016/j.ejmech.2014.07.081
57396172 70328 0 None -512 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 433 7 2 5 4.8 O=C(O)CNCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950481 70328 0 None -512 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 433 7 2 5 4.8 O=C(O)CNCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
66655362 163067 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 423 8 1 4 4.6 CCc1cccc(CC)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4203755 163067 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 423 8 1 4 4.6 CCc1cccc(CC)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
68082485 166959 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4207162 166959 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4300006 166959 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
70695743 72839 0 None -39810 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 516 9 1 6 6.1 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc3c2ccn3CCC(=O)O)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011746 72839 0 None -39810 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 516 9 1 6 6.1 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc3c2ccn3CCC(=O)O)s1 10.1016/j.bmcl.2012.02.016
24824717 120344 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
CHEMBL3360358 120344 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
CHEMBL3558705 120344 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
54758399 65627 0 None -794 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 448 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)CC4)no2)cc1C#N 10.1021/jm200609t
CHEMBL1836172 65627 0 None -794 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 448 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)CC4)no2)cc1C#N 10.1021/jm200609t
44124898 115919 0 None -398 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 369 4 1 5 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360365 115919 0 None -398 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 369 4 1 5 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4)no2)cc1Cl 10.1021/jm5010336
44129142 115921 0 None -125 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 385 4 1 6 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360367 115921 0 None -125 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 385 4 1 6 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1Cl 10.1021/jm5010336
11222939 67233 6 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
44438254 67233 6 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
CHEMBL190006 67233 6 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
44591249 180054 0 None -7 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL475495 180054 0 None -7 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
44412882 76935 0 None -316 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 390 6 1 4 5.8 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208168 76935 0 None -316 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 390 6 1 4 5.8 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
11626664 77575 0 None -1584 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 455 7 1 6 5.1 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C(F)(F)F)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209484 77575 0 None -1584 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 455 7 1 6 5.1 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C(F)(F)F)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
16038017 138888 0 None -14454 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 431 7 1 6 4.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OCC(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL379380 138888 0 None -14454 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 431 7 1 6 4.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OCC(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
10174255 84793 0 None -158 4 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL225575 84793 0 None -158 4 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1016/j.bmcl.2011.12.019
70681815 74927 0 None -8 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 480 5 2 4 5.1 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037127 74927 0 None -8 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 480 5 2 4 5.1 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CC(=O)O)cc21 10.1021/ml200252b
46835922 138925 8 None -4466 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3794064 138925 8 None -4466 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
57570459 87183 0 None -2630 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 462 10 2 4 5.9 C/C(=N\OCc1ccc(C2CCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336085 87183 0 None -2630 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 462 10 2 4 5.9 C/C(=N\OCc1ccc(C2CCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
127046183 139546 0 None -56 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 518 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(-c4ccccc4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800496 139546 0 None -56 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 518 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(-c4ccccc4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
56949019 145462 0 None -79 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1ccc(OC)c(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3918461 145462 0 None -79 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1ccc(OC)c(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
69144915 103957 0 None -107 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 370 7 1 4 4.5 Cc1sc(C(=O)CCc2ccc(OCCO)cc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103661 103957 0 None -107 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 370 7 1 4 4.5 Cc1sc(C(=O)CCc2ccc(OCCO)cc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
46236274 8474 0 None -2 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C(C)C 10.1021/jm100181s
CHEMBL1094501 8474 0 None -2 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C(C)C 10.1021/jm100181s
67172159 142347 0 None -1174 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 497 6 2 6 5.5 CC(N)(CCc1ccc2c(c1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F)C(=O)O nan
CHEMBL3893505 142347 0 None -1174 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 497 6 2 6 5.5 CC(N)(CCc1ccc2c(c1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F)C(=O)O nan
46236930 8889 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 365 4 0 4 4.6 CC(C)/N=C1\S/C(=C\c2ccc(N(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098203 8889 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 365 4 0 4 4.6 CC(C)/N=C1\S/C(=C\c2ccc(N(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
10174255 84793 0 None -158 4 Human 7.8 pEC50 = 7.8 Functional
Activity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
CHEMBL225575 84793 0 None -158 4 Human 7.8 pEC50 = 7.8 Functional
Activity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
127046550 139333 0 None -11 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(OC)c(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799227 139333 0 None -11 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(OC)c(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
127048099 139051 0 None -602 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 518 13 4 10 1.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CCO)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797357 139051 0 None -602 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 518 13 4 10 1.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CCO)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
56948899 147981 0 None 1 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1cc(OC)cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3938390 147981 0 None 1 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1cc(OC)cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
24851764 105302 0 None -295 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126627 105302 0 None -295 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76322127 105612 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 491 11 4 5 4.5 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(Cl)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133705 105612 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 491 11 4 5 4.5 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(Cl)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76321769 105055 0 None -26 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 8 4.0 CCc1c(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)sc(C)c1CC(C)C 10.1021/jm401456d
CHEMBL3121965 105055 0 None -26 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 8 4.0 CCc1c(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)sc(C)c1CC(C)C 10.1021/jm401456d
76318058 105074 0 None -194 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 10 3 8 3.6 CCc1cc(-c2noc(-c3sc(CC)c4c3CCCC4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121985 105074 0 None -194 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 10 3 8 3.6 CCc1cc(-c2noc(-c3sc(CC)c4c3CCCC4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
16737679 57064 0 None -70 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651717 57064 0 None -70 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
76329327 105531 0 None -10 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 485 12 4 5 4.4 CCc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
CHEMBL3132870 105531 0 None -10 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 485 12 4 5 4.4 CCc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
46237180 8776 1 None -14 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1097184 8776 1 None -14 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
11852234 105080 0 None -407 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 10 2 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm401456d
CHEMBL3121991 105080 0 None -407 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 10 2 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm401456d
44218903 105285 0 None -63 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 509 11 3 9 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N1CCCC1 10.1021/jm4014696
CHEMBL3126610 105285 0 None -63 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 509 11 3 9 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N1CCCC1 10.1021/jm4014696
76318199 105304 0 None -389 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cn1 10.1021/jm4014696
CHEMBL3126629 105304 0 None -389 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cn1 10.1021/jm4014696
76311230 105592 0 None -26 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2F)cc1 10.1039/C3MD00079F
CHEMBL3133598 105592 0 None -26 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2F)cc1 10.1039/C3MD00079F
46236399 8476 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 378 3 1 4 5.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C1CCCCC1 10.1021/jm100181s
CHEMBL1094503 8476 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 378 3 1 4 5.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C1CCCCC1 10.1021/jm100181s
25192001 7976 0 None -2 4 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 7976 0 None -2 4 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
118707193 112541 0 None -58 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 449 12 3 5 3.9 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311348 112541 0 None -58 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 449 12 3 5 3.9 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
127046400 139080 0 None -162 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(C(CC)CC)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797486 139080 0 None -162 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(C(CC)CC)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
53322738 57698 0 None -22 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccc(Cc2ccc3sc(-c4ccc(CN5CC(C(=O)O)C5)cc4F)nc3c2)cc1 10.1021/ml100228m
CHEMBL1672566 57698 0 None -22 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccc(Cc2ccc3sc(-c4ccc(CN5CC(C(=O)O)C5)cc4F)nc3c2)cc1 10.1021/ml100228m
46846921 139270 0 None -549 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 442 7 1 7 4.5 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C4CC4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3798775 139270 0 None -549 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 442 7 1 7 4.5 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C4CC4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
58907649 86142 0 None -27 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315814 86142 0 None -27 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11697277 103923 0 None -380 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 412 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCO 10.1021/jm4014373
CHEMBL3102992 103923 0 None -380 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 412 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCO 10.1021/jm4014373
46236666 8701 0 None 5 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 5 1 4 5.0 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCc1ccccc1 10.1021/jm100181s
CHEMBL1096541 8701 0 None 5 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 5 1 4 5.0 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCc1ccccc1 10.1021/jm100181s
76322117 105603 0 None 1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 449 13 4 4 4.1 CC(C)c1ccc(CCCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133608 105603 0 None 1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 449 13 4 4 4.1 CC(C)c1ccc(CCCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
11496072 145491 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 6.1 Cc1cc(C(C)CC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391869 145491 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 6.1 Cc1cc(C(C)CC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
59202022 105062 0 None -436 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 431 9 3 8 2.5 CCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121972 105062 0 None -436 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 431 9 3 8 2.5 CCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
24956674 8769 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097103 8769 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
72793810 104212 0 None -28 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)no2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3105248 104212 0 None -28 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)no2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
44406749 74686 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 565 18 4 10 4.7 C[C@@](N)(CCc1ccc(OCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL203475 74686 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 565 18 4 10 4.7 C[C@@](N)(CCc1ccc(OCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
134319702 166012 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assayAgonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assay
ChEMBL 496 11 3 7 4.2 CCCCOCCOc1nc2c(s1)-c1ccc([C@H]3CC[C@](N)(COP(=O)(O)O)C3)cc1CC2 10.1039/C6MD00539J
CHEMBL4279752 166012 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assayAgonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assay
ChEMBL 496 11 3 7 4.2 CCCCOCCOc1nc2c(s1)-c1ccc([C@H]3CC[C@](N)(COP(=O)(O)O)C3)cc1CC2 10.1039/C6MD00539J
127046741 139472 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800019 139472 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
23121374 58138 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 353 11 2 3 4.2 C/C(=C\c1ccc(OCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.01.029
CHEMBL1683046 58138 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 353 11 2 3 4.2 C/C(=C\c1ccc(OCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.01.029
46846904 139261 0 None -3548 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 466 7 1 7 4.7 CC(F)(F)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3798735 139261 0 None -3548 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 466 7 1 7 4.7 CC(F)(F)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
57570463 87164 0 None -3162 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 510 10 2 4 6.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Cl)c1 10.1021/ml300396r
CHEMBL2336065 87164 0 None -3162 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 510 10 2 4 6.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Cl)c1 10.1021/ml300396r
16737504 57050 0 None -7 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 363 6 1 3 4.8 CC(C)Cc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3)cc2c1 10.1021/ml100227q
CHEMBL1651704 57050 0 None -7 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 363 6 1 3 4.8 CC(C)Cc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3)cc2c1 10.1021/ml100227q
118716183 114404 0 None -36 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 7 2.2 CCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342008 114404 0 None -36 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 7 2.2 CCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
53326641 57692 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672560 57692 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
118716138 114373 0 None -20 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 7 1.9 CCCCCn1cc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)nn1 10.1016/j.ejmech.2014.07.081
CHEMBL3341916 114373 0 None -20 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 7 1.9 CCCCCn1cc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)nn1 10.1016/j.ejmech.2014.07.081
70681687 74626 0 None -6309 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CCNCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
CHEMBL2032430 74626 0 None -6309 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CCNCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
25182782 7546 0 None -691 2 Human 5.7 pEC50 = 5.7 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 431 7 2 6 3.2 CCCN(c1cc(C(=O)Nc2ccc(S(N)(=O)=O)cc2C)ncn1)C1CCCCC1 nan
CHEMBL1088178 7546 0 None -691 2 Human 5.7 pEC50 = 5.7 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 431 7 2 6 3.2 CCCN(c1cc(C(=O)Nc2ccc(S(N)(=O)=O)cc2C)ncn1)C1CCCCC1 nan
145947403 167107 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4205878 167107 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4301965 167107 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
44129144 115885 0 None -15 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 1 7 4.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCC(=O)O)CCO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359839 115885 0 None -15 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 1 7 4.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCC(=O)O)CCO4)no2)cc1Cl 10.1021/jm5010336
44128909 115891 0 None -501 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 6 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359845 115891 0 None -501 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 6 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
44125470 115931 0 None -3 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 441 8 1 6 5.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360377 115931 0 None -3 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 441 8 1 6 5.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
70692257 74629 0 None -1995 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.4 O=C(O)CN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032433 74629 0 None -1995 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.4 O=C(O)CN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70692258 74631 0 None -5011 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 481 5 1 5 5.4 O=C(O)CN1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032435 74631 0 None -5011 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 481 5 1 5 5.4 O=C(O)CN1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70696411 74634 0 None -3981 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032438 74634 0 None -3981 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
70681689 74635 0 None -199 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 438 4 1 4 5.7 O=C(O)C1CN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032439 74635 0 None -199 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 438 4 1 4 5.7 O=C(O)C1CN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44125704 115900 0 None -316 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359854 115900 0 None -316 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
118716180 114401 0 None -47 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 7 2.3 NC(CO)(CCc1ccc(-c2cn(-c3ccc(Cl)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342005 114401 0 None -47 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 7 2.3 NC(CO)(CCc1ccc(-c2cn(-c3ccc(Cl)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11452022 3539 33 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
6996 3539 33 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
CHEMBL366208 3539 33 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
10883396 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
5283560 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
911 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
CHEMBL225155 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
76325528 105265 0 None -7 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCC2)n1 10.1021/jm4014696
CHEMBL3126589 105265 0 None -7 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCC2)n1 10.1021/jm4014696
10883396 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
5283560 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
911 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
CHEMBL225155 3592 39 None 1 14 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
11222939 67233 6 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
44438254 67233 6 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL190006 67233 6 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
66829334 139375 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1CC 10.1016/j.ejmech.2016.03.048
CHEMBL3799441 139375 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1CC 10.1016/j.ejmech.2016.03.048
118707012 112497 0 None -28 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 435 12 3 5 3.5 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311106 112497 0 None -28 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 435 12 3 5 3.5 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmc.2014.05.035
46236403 8550 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
CHEMBL1095153 8550 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
57394951 70560 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccccc1Oc1ccc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951157 70560 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccccc1Oc1ccc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)cc1 10.1016/j.bmcl.2011.12.019
44219368 139193 0 None -251 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798218 139193 0 None -251 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11853580 103916 0 None -181 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 2 5 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCC(=O)O 10.1021/jm4014373
CHEMBL3102985 103916 0 None -181 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 2 5 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCC(=O)O 10.1021/jm4014373
76332956 105593 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)c(F)c2)cc1 10.1039/C3MD00079F
CHEMBL3133599 105593 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)c(F)c2)cc1 10.1039/C3MD00079F
57400585 69539 0 None -48 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 471 5 1 6 4.2 CC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938933 69539 0 None -48 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 471 5 1 6 4.2 CC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
57402358 69534 0 None -19 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
CHEMBL1938927 69534 0 None -19 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
57402280 71148 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935580 71148 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962533 71148 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
76311232 105600 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133605 105600 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
127046325 139095 0 None -208 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.5 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(CC)CC 10.1016/j.ejmech.2016.03.048
CHEMBL3797596 139095 0 None -208 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.5 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(CC)CC 10.1016/j.ejmech.2016.03.048
127047083 139462 0 None -346 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799953 139462 0 None -346 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
76322118 105604 0 None -2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2c1 10.1039/C3MD00079F
CHEMBL3133609 105604 0 None -2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2c1 10.1039/C3MD00079F
127046456 139124 0 None -138 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 4 8 3.2 CCc1cc(-c2noc(-c3cc(C)cc(CNCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797802 139124 0 None -138 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 4 8 3.2 CCc1cc(-c2noc(-c3cc(C)cc(CNCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
118716144 114380 0 None -28 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 7 3.6 NC(CO)(CCc1ccc(-c2coc(-c3ccc(OC(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341922 114380 0 None -28 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 7 3.6 NC(CO)(CCc1ccc(-c2coc(-c3ccc(OC(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46236805 8702 0 None 8 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 428 7 1 4 5.7 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCCCc1ccccc1 10.1021/jm100181s
CHEMBL1096542 8702 0 None 8 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 428 7 1 4 5.7 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCCCc1ccccc1 10.1021/jm100181s
46236934 8967 0 None 2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1O 10.1021/jm100181s
CHEMBL1098772 8967 0 None 2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1O 10.1021/jm100181s
76322128 105615 0 None -6 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 473 11 4 6 3.9 COc1cccc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c1 10.1039/C3MD00079F
CHEMBL3133708 105615 0 None -6 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 473 11 4 6 3.9 COc1cccc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c1 10.1039/C3MD00079F
127047020 139490 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800133 139490 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
118707196 112544 0 None -54 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 469 12 3 5 4.2 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(Cl)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311351 112544 0 None -54 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 469 12 3 5 4.2 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(Cl)c2)cc1 10.1016/j.bmc.2014.05.035
59982944 87163 0 None -7244 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 494 10 2 4 6.4 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(F)c1 10.1021/ml300396r
CHEMBL2336064 87163 0 None -7244 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 494 10 2 4 6.4 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(F)c1 10.1021/ml300396r
11633613 103953 0 None -346 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(CO)CO 10.1021/jm4014373
CHEMBL3103657 103953 0 None -346 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(CO)CO 10.1021/jm4014373
56949269 143896 0 None -21 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 333 5 0 4 5.0 c1ccc(C2(CCc3nc(-c4cccnc4)no3)CCCCC2)cc1 nan
CHEMBL3906369 143896 0 None -21 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 333 5 0 4 5.0 c1ccc(C2(CCc3nc(-c4cccnc4)no3)CCCCC2)cc1 nan
56948778 146456 0 None -4 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 346 5 0 3 5.9 Cc1cccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3926389 146456 0 None -4 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 346 5 0 3 5.9 Cc1cccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
57400476 71314 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935579 71314 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963631 71314 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
76329326 105610 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 471 11 4 5 4.1 Cc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133703 105610 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 471 11 4 5 4.1 Cc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
46236664 8442 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccnc1 10.1021/jm100181s
CHEMBL1094247 8442 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccnc1 10.1021/jm100181s
44422604 85023 0 None -10 5 Human 7.6 pEC50 = 7.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 432 15 4 4 4.4 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CC(F)OP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL226612 85023 0 None -10 5 Human 7.6 pEC50 = 7.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 432 15 4 4 4.4 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CC(F)OP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
11575913 77768 0 None -5 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 444 7 1 5 5.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Br)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210316 77768 0 None -5 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 444 7 1 5 5.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Br)c2)n1 10.1016/j.bmcl.2006.04.084
127046179 139277 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 544 13 3 9 3.9 CCc1cc(-c2noc(-c3sc(CN(C)CC(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798807 139277 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 544 13 3 9 3.9 CCc1cc(-c2noc(-c3sc(CN(C)CC(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
46880801 6189 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 nan
CHEMBL1081646 6189 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 nan
46880801 6189 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1081646 6189 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 10.1016/j.bmcl.2010.01.102
25182774 6050 0 None -11 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 364 4 2 5 3.7 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(C)C2CCCCC2)ncn1 nan
CHEMBL1080881 6050 0 None -11 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 364 4 2 5 3.7 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(C)C2CCCCC2)ncn1 nan
25182928 145436 0 None -81 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 463 9 2 6 3.8 O=C(Nc1ccc(CN2CC(C(=O)O)C2)cc1)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL3918272 145436 0 None -81 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 463 9 2 6 3.8 O=C(Nc1ccc(CN2CC(C(=O)O)C2)cc1)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
46881623 6685 0 None -389 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 477 9 2 6 4.1 Cc1cc(CN2CC(C(=O)O)C2)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1083828 6685 0 None -389 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 477 9 2 6 4.1 Cc1cc(CN2CC(C(=O)O)C2)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
23729211 105058 0 None -154 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3cc(CC(C)C)c(C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121968 105058 0 None -154 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3cc(CC(C)C)c(C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
118716146 114382 0 None -10 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 6 3.9 CC(C)c1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341924 114382 0 None -10 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 6 3.9 CC(C)c1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
76310852 105076 0 None -21 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 525 10 3 8 4.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121987 105076 0 None -21 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 525 10 3 8 4.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
76310992 105260 0 None -239 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.1 CCc1cc(-c2noc(-c3cc(C)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126584 105260 0 None -239 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.1 CCc1cc(-c2noc(-c3cc(C)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76321896 105299 0 None -120 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1C1CCCC1 10.1021/jm4014696
CHEMBL3126624 105299 0 None -120 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1C1CCCC1 10.1021/jm4014696
46237175 8774 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OCC(O)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097182 8774 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OCC(O)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46881912 6688 0 None -5 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 425 13 2 5 2.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCN2CC(=O)NS2(=O)=O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1083841 6688 0 None -5 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 425 13 2 5 2.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCN2CC(=O)NS2(=O)=O)cc1 10.1016/j.bmcl.2010.01.118
57437389 105086 0 None -186 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 11 3 6 4.8 CCc1cc(CCC(=O)c2sc(C(F)(F)F)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121997 105086 0 None -186 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 11 3 6 4.8 CCc1cc(CCC(=O)c2sc(C(F)(F)F)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
5309153 37265 8 None 24 4 Human 6.6 pEC50 = 6.6 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 nan
CHEMBL1455786 37265 8 None 24 4 Human 6.6 pEC50 = 6.6 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 nan
53322737 57696 0 None -93 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccccc1Cc1ccc2sc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)nc2c1 10.1021/ml100228m
CHEMBL1672564 57696 0 None -93 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccccc1Cc1ccc2sc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)nc2c1 10.1021/ml100228m
118716141 114376 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 436 9 4 6 2.9 NC(CO)(CCc1ccc(-c2coc(-c3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341919 114376 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 436 9 4 6 2.9 NC(CO)(CCc1ccc(-c2coc(-c3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46236522 8841 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1c(Cl)cccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1097809 8841 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1c(Cl)cccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
66636847 105059 0 None -407 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 10 3 8 3.1 Cc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121969 105059 0 None -407 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 10 3 8 3.1 Cc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46880964 7517 0 None -416 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 457 8 2 6 3.5 CNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
CHEMBL1087909 7517 0 None -416 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 457 8 2 6 3.5 CNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
76328931 105067 0 None -63 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 472 11 2 5 5.8 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(CC)(CC)CC2 10.1021/jm401456d
CHEMBL3121978 105067 0 None -63 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 472 11 2 5 5.8 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(CC)(CC)CC2 10.1021/jm401456d
76336214 105085 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 13 3 6 4.8 CCCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121996 105085 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 13 3 6 4.8 CCCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
76325529 105266 0 None -12 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 522 11 3 8 4.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCCC2)n1 10.1021/jm4014696
CHEMBL3126590 105266 0 None -12 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 522 11 3 8 4.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCCC2)n1 10.1021/jm4014696
76314625 105297 0 None -251 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126622 105297 0 None -251 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25192001 7976 0 None -2 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 7976 0 None -2 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
57391921 69544 0 None -61 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1nc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938938 69544 0 None -61 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1nc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395370 69545 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ncccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938939 69545 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ncccc21 10.1016/j.bmcl.2011.10.085
57402391 69546 0 None -104 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938940 69546 0 None -104 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57395371 69547 0 None -87 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccncc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938941 69547 0 None -87 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccncc21 10.1016/j.bmcl.2011.10.085
57395372 69548 0 None -13 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccnc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938942 69548 0 None -13 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccnc21 10.1016/j.bmcl.2011.10.085
57393649 69549 0 None -60 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938943 69549 0 None -60 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395373 69550 0 None -2 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cc(C(F)(F)F)c(-c3ccccc3)cn2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938944 69550 0 None -2 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cc(C(F)(F)F)c(-c3ccccc3)cn2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395374 69551 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cnc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938945 69551 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cnc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57402392 69552 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938946 69552 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57400586 69553 0 None -8 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3cccnc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938947 69553 0 None -8 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3cccnc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57400587 69554 0 None -5 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccncc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938948 69554 0 None -5 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccncc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
56834955 69555 0 None -125 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938949 69555 0 None -125 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57400588 69556 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938950 69556 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57398897 69557 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 425 3 1 6 3.7 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938951 69557 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 425 3 1 6 3.7 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57570467 87162 0 None -147 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 466 10 2 5 5.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)o1 10.1021/ml300396r
CHEMBL2336063 87162 0 None -147 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 466 10 2 5 5.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)o1 10.1021/ml300396r
16737513 57055 0 None -11 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 379 8 1 4 4.8 CCCCOc1ccc2cc(-c3ccc(CN4CC(C(=O)O)C4)cc3)oc2c1 10.1021/ml100227q
CHEMBL1651709 57055 0 None -11 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 379 8 1 4 4.8 CCCCOc1ccc2cc(-c3ccc(CN4CC(C(=O)O)C4)cc3)oc2c1 10.1021/ml100227q
44125589 115897 0 None -100 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 2 7 4.6 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(CCC(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359851 115897 0 None -100 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 2 7 4.6 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(CCC(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
70694325 74624 0 None -7943 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CNCCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
CHEMBL2032428 74624 0 None -7943 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CNCCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
53323421 57101 0 None -75 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 461 6 1 5 5.3 CC(C)(c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651860 57101 0 None -75 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 461 6 1 5 5.3 CC(C)(c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
54576721 75692 0 None -3162 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 474 9 1 6 5.1 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(CC(C)C)c(C#N)c2)n1 10.1021/jm2016107
CHEMBL2057286 75692 0 None -3162 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 474 9 1 6 5.1 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(CC(C)C)c(C#N)c2)n1 10.1021/jm2016107
57522812 76094 0 None -10000 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 505 8 1 6 5.8 CCc1c(CN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059686 76094 0 None -10000 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 505 8 1 6 5.8 CCc1c(CN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
54576288 76095 0 None -25118 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 547 9 1 6 6.6 CCc1c(CCN2CCC(C(=O)O)CC2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059687 76095 0 None -25118 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 547 9 1 6 6.6 CCc1c(CCN2CCC(C(=O)O)CC2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
107970 1609 76 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
2407 1609 76 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
4167 1609 76 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
CHEMBL314854 1609 76 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
DB08868 1609 76 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
70689433 72828 0 None -10 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc(S(=O)(=O)NCCC(=O)O)c2)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011735 72828 0 None -10 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc(S(=O)(=O)NCCC(=O)O)c2)s1 10.1016/j.bmcl.2012.02.016
49842175 65626 0 None -19952 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 489 8 2 8 3.2 Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(CC(=O)N[C@@H](C)CO)C2 10.1021/jm200609t
CHEMBL1836171 65626 0 None -19952 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 489 8 2 8 3.2 Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(CC(=O)N[C@@H](C)CO)C2 10.1021/jm200609t
44129145 115887 0 None -398 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 462 8 1 8 4.1 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCCC(=O)O)CCO4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359841 115887 0 None -398 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 462 8 1 8 4.1 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCCC(=O)O)CCO4)no2)cc1C#N 10.1021/jm5010336
42636536 115899 0 None -2511 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 471 8 2 7 5.1 CC(C)Oc1ccc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359853 115899 0 None -2511 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 471 8 2 7 5.1 CC(C)Oc1ccc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
76329073 105271 0 None -288 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126596 105271 0 None -288 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46237047 8806 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 0 3 5.2 CC(C)/N=C1\S/C(=C\c2ccccc2Cl)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097527 8806 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 0 3 5.2 CC(C)/N=C1\S/C(=C\c2ccccc2Cl)C(=O)N1c1ccccc1 10.1021/jm100181s
25182909 5954 0 None -21 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 10 3 7 2.9 Cc1cc(S(=O)(=O)NCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1080384 5954 0 None -21 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 10 3 7 2.9 Cc1cc(S(=O)(=O)NCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
69143673 103963 0 None -446 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 384 7 1 4 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)ccc1OCCO 10.1021/jm4014373
CHEMBL3103667 103963 0 None -446 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 384 7 1 4 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)ccc1OCCO 10.1021/jm4014373
76318055 105050 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCC(=O)O 10.1021/jm401456d
CHEMBL3121960 105050 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCC(=O)O 10.1021/jm401456d
46846902 139234 0 None -501 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 6 1 7 4.9 CC(C)(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3798531 139234 0 None -501 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 6 1 7 4.9 CC(C)(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
44625753 87160 0 None -1862 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cn1 10.1021/ml300396r
CHEMBL2336061 87160 0 None -1862 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cn1 10.1021/ml300396r
44439851 145114 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391581 145114 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
76310994 105296 0 None -2951 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cnc(C(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126621 105296 0 None -2951 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cnc(C(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
24956676 8437 0 None -2 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 5 1 4 5.3 CCCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094213 8437 0 None -2 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 5 1 4 5.3 CCCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
44439851 145114 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391581 145114 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
57395369 69542 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 5 1 6 4.5 CC1(C)SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938936 69542 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 5 1 6 4.5 CC1(C)SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
11452022 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
6996 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
CHEMBL366208 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
68547259 139446 0 None -89 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(CC(C)C)nc(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799872 139446 0 None -89 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(CC(C)C)nc(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11452022 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
6996 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
CHEMBL366208 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
11452022 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
6996 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
CHEMBL366208 3539 33 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
44422573 85131 0 None -10 4 Human 6.6 pEC50 = 6.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227851 85131 0 None -10 4 Human 6.6 pEC50 = 6.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
16737679 57064 0 None -70 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
CHEMBL1651717 57064 0 None -70 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
53324301 57689 0 None -1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672557 57689 0 None -1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
24825339 91334 0 None -6309 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 392 7 1 7 3.8 Cc1nc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL241052 91334 0 None -6309 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 392 7 1 7 3.8 Cc1nc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
11567535 103958 0 None -602 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 8 1 5 4.5 COc1cc(OCCO)ccc1CCC(=O)c1sc(C)c2c1C[C@@H]1[C@H]2C1(C)C 10.1021/jm4014373
CHEMBL3103662 103958 0 None -602 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 8 1 5 4.5 COc1cc(OCCO)ccc1CCC(=O)c1sc(C)c2c1C[C@@H]1[C@H]2C1(C)C 10.1021/jm4014373
44565715 179861 0 None -3 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475253 179861 0 None -3 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11222939 67233 6 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
44438254 67233 6 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
CHEMBL190006 67233 6 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
11853338 104242 0 None -263 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 8 0 4 5.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN(C)C 10.1021/jm4014373
CHEMBL3105491 104242 0 None -263 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 8 0 4 5.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN(C)C 10.1021/jm4014373
44565739 178382 0 None -33 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL470511 178382 0 None -33 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
69263869 104230 0 None -660 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 436 6 1 5 6.0 CCc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1CCC(=O)O 10.1021/jm4014373
CHEMBL3105479 104230 0 None -660 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 436 6 1 5 6.0 CCc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1CCC(=O)O 10.1021/jm4014373
53318125 57094 0 None -20 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)cnc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651853 57094 0 None -20 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)cnc4s3)c(F)c2)C1 10.1021/ml100306h
68762699 105298 0 None -288 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1CC(C)C 10.1021/jm4014696
CHEMBL3126623 105298 0 None -288 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1CC(C)C 10.1021/jm4014696
57395262 71152 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935578 71152 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962545 71152 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
76318200 105305 0 None -741 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccc(C(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126630 105305 0 None -741 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccc(C(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
127046095 139258 0 None -9 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798722 139258 0 None -9 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
57402284 71149 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
CHEMBL1935585 71149 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
CHEMBL1962534 71149 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
118716148 114384 0 None -19 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 7 2.6 N#Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341926 114384 0 None -19 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 7 2.6 N#Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
11452022 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
6996 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
CHEMBL366208 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
10883396 3592 39 None 1 14 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
5283560 3592 39 None 1 14 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
911 3592 39 None 1 14 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
CHEMBL225155 3592 39 None 1 14 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
11452022 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
6996 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
CHEMBL366208 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
11452022 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
6996 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
CHEMBL366208 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
11452022 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
6996 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
CHEMBL366208 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
44217654 139565 0 None -1 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 15 3 8 4.2 CCCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3800604 139565 0 None -1 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 15 3 8 4.2 CCCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
2924 1610 37 None -10 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
44398069 1610 37 None -10 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
9908268 1610 37 None -10 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
CHEMBL114606 1610 37 None -10 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
76314621 105263 0 None -18 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 510 13 3 8 4.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C(CC)CC)n1 10.1021/jm4014696
CHEMBL3126587 105263 0 None -18 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 510 13 3 8 4.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C(CC)CC)n1 10.1021/jm4014696
2924 1610 37 None -10 6 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
44398069 1610 37 None -10 6 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
9908268 1610 37 None -10 6 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
CHEMBL114606 1610 37 None -10 6 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
76322116 105602 0 None 54 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCc1ccc(CCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133607 105602 0 None 54 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCc1ccc(CCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
10883396 3592 39 None 1 14 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
5283560 3592 39 None 1 14 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
911 3592 39 None 1 14 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
CHEMBL225155 3592 39 None 1 14 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
44218604 105283 0 None -100 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 13 3 9 2.9 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N(CC)CC 10.1021/jm4014696
CHEMBL3126608 105283 0 None -100 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 13 3 9 2.9 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N(CC)CC 10.1021/jm4014696
45377662 83702 0 None -1000 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 468 9 1 6 4.3 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207778 83702 0 None -1000 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 468 9 1 6 4.3 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
58390859 83714 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 484 9 1 6 4.8 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207791 83714 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 484 9 1 6 4.8 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
46866185 7251 0 None -15 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 321 12 2 3 4.2 CCCCCCCOc1ccc(CC[C@](C)(N)CC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1086172 7251 0 None -15 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 321 12 2 3 4.2 CCCCCCCOc1ccc(CC[C@](C)(N)CC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
57394952 70561 0 None -144 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1cc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)ccc1Oc1ccccc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951158 70561 0 None -144 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1cc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)ccc1Oc1ccccc1 10.1016/j.bmcl.2011.12.019
23121172 63105 0 None -301 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 12 2 3 4.6 C/C(=C\c1ccc(OCCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.05.029
CHEMBL1797506 63105 0 None -301 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 12 2 3 4.6 C/C(=C\c1ccc(OCCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.05.029
57570487 87181 0 None -199 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 460 10 2 5 5.5 C/C(=N\OCc1ccc(-c2ccco2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336083 87181 0 None -199 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 460 10 2 5 5.5 C/C(=N\OCc1ccc(-c2ccco2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
118716178 114399 0 None -23 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 8 1.7 COc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342003 114399 0 None -23 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 8 1.7 COc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
76322119 105607 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 423 12 4 5 3.6 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133612 105607 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 423 12 4 5 3.6 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46236272 8512 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 398 3 1 4 5.5 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094834 8512 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 398 3 1 4 5.5 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCC2)N1c1ccccc1 10.1021/jm100181s
46236517 8927 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(C)c1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1098467 8927 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(C)c1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
25072410 105269 0 None -162 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cc(C)nc(N4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126593 105269 0 None -162 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cc(C)nc(N4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76329076 105287 0 None -707 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CC(C)C)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126612 105287 0 None -707 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CC(C)C)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11678855 133920 0 None -31 3 Human 7.5 pEC50 = 7.5 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 607 21 4 10 5.9 C[C@@](N)(CCc1ccc(OCCCCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL371758 133920 0 None -31 3 Human 7.5 pEC50 = 7.5 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 607 21 4 10 5.9 C[C@@](N)(CCc1ccc(OCCCCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
46236273 8435 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 3 1 4 5.9 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094193 8435 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 3 1 4 5.9 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCCC2)N1c1ccccc1 10.1021/jm100181s
25032056 105256 0 None -776 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.8 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126435 105256 0 None -776 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.8 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
46195467 148825 0 None -17 2 Human 6.5 pEC50 = 6.5 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 482 12 3 9 3.0 CCCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCCC nan
CHEMBL3945262 148825 0 None -17 2 Human 6.5 pEC50 = 6.5 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 482 12 3 9 3.0 CCCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCCC nan
46881876 5525 0 None -12 3 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 335 13 2 3 4.6 CCCCCCCOc1ccc(CC[C@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1077288 5525 0 None -12 3 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 335 13 2 3 4.6 CCCCCCCOc1ccc(CC[C@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
127046992 139506 0 None -61 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 508 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CN4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800230 139506 0 None -61 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 508 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CN4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44547414 68001 0 None -2398 6 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assayAgonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assay
ChEMBL 499 5 1 5 5.2 O=C(O)CCC(=O)N1CCc2cc(-c3noc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)ccc21 10.1016/j.bmcl.2011.05.110
CHEMBL1916559 68001 0 None -2398 6 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assayAgonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assay
ChEMBL 499 5 1 5 5.2 O=C(O)CCC(=O)N1CCc2cc(-c3noc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)ccc21 10.1016/j.bmcl.2011.05.110
11852848 105088 0 None -186 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 9 3 8 3.7 CCc1cc(-c2noc(-c3scc4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121999 105088 0 None -186 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 9 3 8 3.7 CCc1cc(-c2noc(-c3scc4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
54576289 76096 0 None -12589 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 519 9 1 6 5.8 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059688 76096 0 None -12589 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 519 9 1 6 5.8 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
57505996 115918 1 None -7943 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 360 4 1 6 3.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCNC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360364 115918 1 None -7943 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 360 4 1 6 3.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCNC4)no2)cc1C#N 10.1021/jm5010336
46236806 8641 0 None 3 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 322 3 0 3 4.6 CC(C)/N=C1\S/C(=C\c2ccccc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1095987 8641 0 None 3 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 322 3 0 3 4.6 CC(C)/N=C1\S/C(=C\c2ccccc2)C(=O)N1c1ccccc1 10.1021/jm100181s
68763522 105308 0 None -316 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126633 105308 0 None -316 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
24784418 105301 0 None -446 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 11 3 8 3.4 CCc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126626 105301 0 None -446 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 11 3 8 3.4 CCc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11315809 71313 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935576 71313 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963630 71313 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
57570476 87169 0 None -1995 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 502 8 1 4 6.5 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CN2CC(C(=O)O)C2)c(C)c1 10.1021/ml300396r
CHEMBL2336070 87169 0 None -1995 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 502 8 1 4 6.5 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CN2CC(C(=O)O)C2)c(C)c1 10.1021/ml300396r
44217170 139218 0 None -446 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3ccc(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798420 139218 0 None -446 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3ccc(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
25182776 147145 0 None -17 2 Human 4.5 pEC50 = 4.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 365 4 2 5 3.0 CN(c1cc(C(=O)Nc2ccc3c(c2)CC(=O)N3)ncn1)C1CCCCC1 nan
CHEMBL3931810 147145 0 None -17 2 Human 4.5 pEC50 = 4.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 365 4 2 5 3.0 CN(c1cc(C(=O)Nc2ccc3c(c2)CC(=O)N3)ncn1)C1CCCCC1 nan
25182901 5952 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1080382 5952 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
25182901 5952 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1080382 5952 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
68555865 105257 0 None -331 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)nc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126436 105257 0 None -331 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)nc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
59446971 153532 0 None -173 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 11 2 7 3.5 COCCNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
CHEMBL3984678 153532 0 None -173 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 11 2 7 3.5 COCCNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
11313781 58137 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
11313781 58137 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
CHEMBL1683045 58137 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683045 58137 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
11371585 63103 0 None -77 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 351 9 1 3 3.7 O=C(O)C1CN(C/C=C/c2ccc(OCCCc3ccccc3)cc2)C1 10.1016/j.bmcl.2011.05.029
CHEMBL1797504 63103 0 None -77 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 351 9 1 3 3.7 O=C(O)C1CN(C/C=C/c2ccc(OCCCc3ccccc3)cc2)C1 10.1016/j.bmcl.2011.05.029
46236520 8812 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 4 1 4 5.5 CCc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1097537 8812 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 4 1 4 5.5 CCc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
46236810 8886 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1098200 8886 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
44412994 77917 0 None -3388 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 499 7 1 6 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C(F)(F)F)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210942 77917 0 None -3388 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 499 7 1 6 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C(F)(F)F)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
118707198 112546 0 None -154 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 12 3 5 4.2 Cc1ccc(CCCC(=O)c2cc(C)c(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311353 112546 0 None -154 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 12 3 5 4.2 Cc1ccc(CCCC(=O)c2cc(C)c(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
11854090 104209 0 None -776 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 9 2 5 4.3 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(=O)NCCO 10.1021/jm4014373
CHEMBL3105245 104209 0 None -776 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 9 2 5 4.3 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(=O)NCCO 10.1021/jm4014373
16737507 57063 0 None -8 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)cc2F)C1 10.1021/ml100227q
CHEMBL1651716 57063 0 None -8 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)cc2F)C1 10.1021/ml100227q
46224767 197618 0 None -48 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 293 2 0 4 3.2 Cc1nn(C(=O)/C=C/c2ccncc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL590383 197618 0 None -48 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 293 2 0 4 3.2 Cc1nn(C(=O)/C=C/c2ccncc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
53324746 57095 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651854 57095 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100228m
51346934 57690 27 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672558 57690 27 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
53324746 57095 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651854 57095 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
72793790 104231 0 None -100 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 13 3 6 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(CC(=O)O)C(=O)O 10.1021/jm4014373
CHEMBL3105480 104231 0 None -100 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 13 3 6 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(CC(=O)O)C(=O)O 10.1021/jm4014373
76318445 105596 0 None -12 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 496 11 4 7 4.1 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)c(Cl)c3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133601 105596 0 None -12 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 496 11 4 7 4.1 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)c(Cl)c3)cc2)co1 10.1039/C3MD00079F
46236932 8965 0 None 5 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1cccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)c1 10.1021/jm100181s
CHEMBL1098770 8965 0 None 5 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1cccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)c1 10.1021/jm100181s
2924 1610 37 None -10 6 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
44398069 1610 37 None -10 6 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
9908268 1610 37 None -10 6 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
CHEMBL114606 1610 37 None -10 6 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
11676168 70606 9 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1016/j.ejmech.2012.02.022
CHEMBL1951588 70606 9 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1016/j.ejmech.2012.02.022
11676168 70606 9 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1021/ml100301k
CHEMBL1951588 70606 9 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1021/ml100301k
46236518 8810 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1C 10.1021/jm100181s
CHEMBL1097535 8810 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1C 10.1021/jm100181s
44219528 139167 0 None -66 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798068 139167 0 None -66 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
25074253 105268 9 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3126592 105268 9 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
67172039 148458 0 None -3235 2 Human 5.5 pEC50 = 5.5 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F nan
CHEMBL3942289 148458 0 None -3235 2 Human 5.5 pEC50 = 5.5 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F nan
25074253 105268 9 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126592 105268 9 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
53322715 57683 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672550 57683 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
118716143 114379 0 None -32 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 6 3.8 NC(CO)(CCc1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341921 114379 0 None -32 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 6 3.8 NC(CO)(CCc1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
127045963 139303 0 None -26 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c(C)c1C 10.1016/j.ejmech.2016.03.048
CHEMBL3799029 139303 0 None -26 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c(C)c1C 10.1016/j.ejmech.2016.03.048
76318196 105281 0 None -446 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126606 105281 0 None -446 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014696
127046551 139166 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(C)c(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798060 139166 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(C)c(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
25192005 7654 0 None -3 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1089004 7654 0 None -3 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
44219370 139199 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3798240 139199 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
73774584 105613 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 443 10 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133706 105613 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 443 10 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76318057 105065 0 None -190 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 416 9 2 5 4.4 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CCCC2 10.1021/jm401456d
CHEMBL3121976 105065 0 None -190 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 416 9 2 5 4.4 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CCCC2 10.1021/jm401456d
53320107 57700 0 None -79 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(Cl)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672568 57700 0 None -79 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(Cl)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
46195468 151985 0 None -5 2 Human 7.4 pEC50 = 7.4 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3ccc4c(c3)CN(CC(N)(CO)CO)C4)no2)cc1OCC nan
CHEMBL3971409 151985 0 None -5 2 Human 7.4 pEC50 = 7.4 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3ccc4c(c3)CN(CC(N)(CO)CO)C4)no2)cc1OCC nan
56835182 69540 0 None -30 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938934 69540 0 None -30 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
57404009 71319 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935577 71319 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963645 71319 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
76318446 105608 0 None -4 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 457 11 4 5 3.8 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133613 105608 0 None -4 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 457 11 4 5 3.8 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76321773 105087 0 None -3019 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 517 12 3 7 3.8 CCc1cc(CCC(=O)c2sc(OC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121998 105087 0 None -3019 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 517 12 3 7 3.8 CCc1cc(CCC(=O)c2sc(OC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
11852952 105078 0 None -776 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 6 3.9 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121989 105078 0 None -776 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 6 3.9 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
76336361 105278 1 None -12882 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126603 105278 1 None -12882 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
66655211 167174 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4205124 167174 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4302786 167174 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
118723864 115888 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 7 1 7 3.9 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)C4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359842 115888 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 7 1 7 3.9 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)C4)no2)cc1C#N 10.1021/jm5010336
46205775 8145 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 475 11 4 5 3.8 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1092272 8145 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 475 11 4 5 3.8 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
46206105 8151 0 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 477 10 4 5 4.4 NC(CO)(CCc1ccc(-c2ccc(Sc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1092286 8151 0 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 477 10 4 5 4.4 NC(CO)(CCc1ccc(-c2ccc(Sc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
11852237 104211 0 None -37 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3105247 104211 0 None -37 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
70681384 73813 0 None -363 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor by [S35]GTPgammaS binding assayAgonist activity at human S1P3 receptor by [S35]GTPgammaS binding assay
ChEMBL 484 10 1 6 6.4 CCCc1cc(-c2cnc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)s2)ccc1OC(C)C 10.1016/j.bmcl.2012.03.067
CHEMBL2022905 73813 0 None -363 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor by [S35]GTPgammaS binding assayAgonist activity at human S1P3 receptor by [S35]GTPgammaS binding assay
ChEMBL 484 10 1 6 6.4 CCCc1cc(-c2cnc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)s2)ccc1OC(C)C 10.1016/j.bmcl.2012.03.067
11662328 91333 0 None -1318 3 Human 6.4 pEC50 = 6.4 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 5.8 Cc1cc(CC(C)C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL241050 91333 0 None -1318 3 Human 6.4 pEC50 = 6.4 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 5.8 Cc1cc(CC(C)C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
57570503 87161 0 None -1819 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 482 10 2 5 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)s1 10.1021/ml300396r
CHEMBL2336062 87161 0 None -1819 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 482 10 2 5 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)s1 10.1021/ml300396r
67414717 103954 0 None -288 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 397 7 1 4 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN 10.1021/jm4014373
CHEMBL3103658 103954 0 None -288 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 397 7 1 4 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN 10.1021/jm4014373
11501873 139617 0 None -2137 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 384 7 1 5 4.7 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(F)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL380253 139617 0 None -2137 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 384 7 1 5 4.7 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(F)c2)n1 10.1016/j.bmcl.2006.04.084
46846820 139522 0 None -4168 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3800349 139522 0 None -4168 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
25182899 6046 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 nan
CHEMBL1080865 6046 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 nan
25182899 6046 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1080865 6046 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 10.1016/j.bmcl.2010.01.102
118716145 114381 0 None -16 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341923 114381 0 None -16 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
44565622 178760 0 None -5 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473562 178760 0 None -5 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
9969355 58133 0 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 369 14 2 3 4.5 O=C(O)CCNCCCc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683041 58133 0 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 369 14 2 3 4.5 O=C(O)CCNCCCc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
67416434 104243 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN 10.1021/jm4014373
CHEMBL3105492 104243 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN 10.1021/jm4014373
46236521 8839 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1Cl 10.1021/jm100181s
CHEMBL1097807 8839 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1Cl 10.1021/jm100181s
44199411 139308 0 None -165 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3799086 139308 0 None -165 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
11597340 103919 0 None -3890 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 438 7 1 4 5.8 Cc1sc(C(=O)CCc2cc(Cl)c(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3102988 103919 0 None -3890 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 438 7 1 4 5.8 Cc1sc(C(=O)CCc2cc(Cl)c(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
46236660 8875 0 None -3 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1098144 8875 0 None -3 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
76325530 105272 0 None -331 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)cc(N(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126597 105272 0 None -331 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)cc(N(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76336364 105295 0 None -4265 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 10 3 8 2.9 CCc1cc(-c2noc(-c3cnc(C(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126620 105295 0 None -4265 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 10 3 8 2.9 CCc1cc(-c2noc(-c3cnc(C(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
44422601 85155 0 None -11 5 Human 7.4 pEC50 = 7.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 398 14 4 3 4.2 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL228139 85155 0 None -11 5 Human 7.4 pEC50 = 7.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 398 14 4 3 4.2 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
11854607 104235 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3105484 104235 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
56949140 146727 0 None -83 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 367 5 0 4 5.6 Clc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
CHEMBL3928616 146727 0 None -83 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 367 5 0 4 5.6 Clc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
68280743 147388 0 None -11 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
CHEMBL3933624 147388 0 None -11 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
25110406 1270 47 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
2928 1270 47 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
CHEMBL3922179 1270 47 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
57570461 87185 0 None -1659 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)nc1 10.1021/ml300396r
CHEMBL2336087 87185 0 None -1659 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)nc1 10.1021/ml300396r
44218451 139087 0 None -1230 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 522 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN1CCCC1 10.1016/j.ejmech.2016.03.048
CHEMBL3797541 139087 0 None -1230 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 522 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN1CCCC1 10.1016/j.ejmech.2016.03.048
127047780 139176 0 None -14 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798148 139176 0 None -14 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
11854607 104235 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
CHEMBL3105484 104235 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
2924 1610 37 None -10 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
44398069 1610 37 None -10 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
9908268 1610 37 None -10 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
CHEMBL114606 1610 37 None -10 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
127045962 139485 0 None -676 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 11 3 9 2.9 CCc1cc(-c2noc(-c3sc(CN(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800102 139485 0 None -676 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 11 3 9 2.9 CCc1cc(-c2noc(-c3sc(CN(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
52914984 147025 0 None -5011 2 Human 5.4 pEC50 = 5.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
CHEMBL3930827 147025 0 None -5011 2 Human 5.4 pEC50 = 5.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
11852953 105083 0 None -3630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 6 4.1 CCc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121994 105083 0 None -3630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 6 4.1 CCc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
11852049 105093 0 None -234 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 7 1 4 5.4 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCO 10.1021/jm401456d
CHEMBL3122003 105093 0 None -234 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 7 1 4 5.4 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCO 10.1021/jm401456d
11852142 105094 0 None -63 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 414 8 1 4 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCCO 10.1021/jm401456d
CHEMBL3122004 105094 0 None -63 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 414 8 1 4 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCCO 10.1021/jm401456d
66829275 139102 0 None -147 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.8 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)sc1CN(C)C 10.1016/j.ejmech.2016.03.048
CHEMBL3797647 139102 0 None -147 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.8 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)sc1CN(C)C 10.1016/j.ejmech.2016.03.048
11588811 3949 39 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
136212600 3949 39 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
3324 3949 39 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
CHEMBL228102 3949 39 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
57391849 70574 0 None -1479 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951312 70574 0 None -1479 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C)cc2)n1 10.1016/j.bmcl.2011.12.019
58344526 149595 2 None -28183 5 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCCO)no2)cc1C#N nan
CHEMBL3951270 149595 2 None -28183 5 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCCO)no2)cc1C#N nan
58390949 83700 0 None -81 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 442 10 2 6 4.0 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207776 83700 0 None -81 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 442 10 2 6 4.0 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
46236519 8811 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(C)c1 10.1021/jm100181s
CHEMBL1097536 8811 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(C)c1 10.1021/jm100181s
25031140 105163 0 None -229 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cc(C)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3124957 105163 0 None -229 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cc(C)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11646599 77313 0 None -2290 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 380 7 1 5 4.8 Cc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
CHEMBL208898 77313 0 None -2290 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 380 7 1 5 4.8 Cc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
44412867 79332 0 None -1148 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 420 7 1 5 5.1 CCOc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C(F)(F)F 10.1016/j.bmcl.2006.04.084
CHEMBL211689 79332 0 None -1148 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 420 7 1 5 5.1 CCOc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C(F)(F)F 10.1016/j.bmcl.2006.04.084
57396699 70555 0 None -537 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2cc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951152 70555 0 None -537 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2cc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
127046866 139310 0 None -676 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 12 3 9 2.6 CCc1cc(-c2noc(-c3ccc(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799109 139310 0 None -676 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 12 3 9 2.6 CCc1cc(-c2noc(-c3ccc(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
69144360 103964 0 None -478 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103668 103964 0 None -478 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
67171242 148090 0 None -141 2 Human 5.3 pEC50 = 5.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 523 5 1 6 6.1 O=C(O)[C@H]1CCCN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
CHEMBL3939314 148090 0 None -141 2 Human 5.3 pEC50 = 5.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 523 5 1 6 6.1 O=C(O)[C@H]1CCCN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
44600645 57106 0 None -123 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 458 6 1 4 5.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651865 57106 0 None -123 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 458 6 1 4 5.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)cc4s3)c(F)c2)C1 10.1021/ml100306h
118716185 114406 0 None -245 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 7 2.6 CCCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342010 114406 0 None -245 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 7 2.6 CCCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
68553624 105261 0 None -234 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126585 105261 0 None -234 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11540052 179985 0 None -33 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475405 179985 0 None -33 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11611053 77589 0 None -524 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 5 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C(F)(F)C(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209567 77589 0 None -524 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 5 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C(F)(F)C(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
44412936 138237 0 None -6606 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 405 8 1 6 4.8 CC[C@H](C)Oc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C#N 10.1016/j.bmcl.2006.04.084
CHEMBL378054 138237 0 None -6606 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 405 8 1 6 4.8 CC[C@H](C)Oc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C#N 10.1016/j.bmcl.2006.04.084
25182773 7545 0 None -26915 3 Human 4.3 pEC50 = 4.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 443 7 2 6 3.2 Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1088177 7545 0 None -26915 3 Human 4.3 pEC50 = 4.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 443 7 2 6 3.2 Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
53322061 57098 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651857 57098 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)nc4s3)c(F)c2)C1 10.1021/ml100306h
44218131 139456 0 None -371 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)C 10.1016/j.ejmech.2016.03.048
CHEMBL3799916 139456 0 None -371 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)C 10.1016/j.ejmech.2016.03.048
16736754 57067 0 None -16 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 395 7 1 4 4.5 O=C(O)C1CN(Cc2ccc(-c3cc4cc(OCC5CC5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
CHEMBL1651720 57067 0 None -16 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 395 7 1 4 4.5 O=C(O)C1CN(Cc2ccc(-c3cc4cc(OCC5CC5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
58390878 83703 0 None -380 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.7 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207779 83703 0 None -380 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.7 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
53320363 57699 0 None -117 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5Cl)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672567 57699 0 None -117 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5Cl)ccc4s3)c(F)c2)C1 10.1021/ml100228m
11690483 103952 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@H](O)CO 10.1021/jm4014373
CHEMBL3103656 103952 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@H](O)CO 10.1021/jm4014373
118716184 114405 0 None -17 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 7 2.8 CC(C)c1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342009 114405 0 None -17 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 7 2.8 CC(C)c1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
76314622 105264 0 None -50 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 11 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCC2)n1 10.1021/jm4014696
CHEMBL3126588 105264 0 None -50 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 11 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCC2)n1 10.1021/jm4014696
11452022 3539 33 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
6996 3539 33 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
CHEMBL366208 3539 33 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
44406009 72364 0 None 10 4 Human 8.3 pEC50 = 8.3 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 515 18 5 10 3.4 N[C@@H](COP(=O)(O)O)[C@H](O)/C=C/CCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12 10.1016/j.bmcl.2005.09.038
CHEMBL199754 72364 0 None 10 4 Human 8.3 pEC50 = 8.3 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 515 18 5 10 3.4 N[C@@H](COP(=O)(O)O)[C@H](O)/C=C/CCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12 10.1016/j.bmcl.2005.09.038
46881847 6980 0 None -6 4 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1084929 6980 0 None -6 4 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
76336211 105051 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 11 2 7 5.9 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCNCCC(=O)O 10.1021/jm401456d
CHEMBL3121961 105051 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 11 2 7 5.9 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCNCCC(=O)O 10.1021/jm401456d
46236809 8643 0 None -1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 3 1 4 4.6 Cc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1095995 8643 0 None -1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 3 1 4 4.6 Cc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
127046743 139294 0 None -45 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 12 3 9 3.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCCC2)n1 10.1016/j.ejmech.2016.03.020
CHEMBL3798969 139294 0 None -45 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 12 3 9 3.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCCC2)n1 10.1016/j.ejmech.2016.03.020
44412971 138405 0 None -16595 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 445 7 1 6 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL378436 138405 0 None -16595 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 445 7 1 6 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
57398802 71147 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935575 71147 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962532 71147 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
44599207 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
5326 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
9289 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
CHEMBL2336071 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
DB12371 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
57404344 72829 0 None -398 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2ccc(S(=O)(=O)NCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011736 72829 0 None -398 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2ccc(S(=O)(=O)NCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.02.016
70681688 74632 0 None -3162 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.5 O=C(O)C1CCN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032436 74632 0 None -3162 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.5 O=C(O)C1CCN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70685939 74633 0 None -630 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032437 74633 0 None -630 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
44129298 115894 0 None -251 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 6 2 6 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359848 115894 0 None -251 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 6 2 6 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1Cl 10.1021/jm5010336
72793788 104244 0 None -741 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 9 1 4 5.8 CNCCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105493 104244 0 None -741 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 9 1 4 5.8 CNCCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
76329311 105606 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 415 12 4 5 3.1 CCCCCCC1CCc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2O1 10.1039/C3MD00079F
CHEMBL3133611 105606 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 415 12 4 5 3.1 CCCCCCC1CCc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2O1 10.1039/C3MD00079F
11697911 14104 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
CHEMBL1089557 14104 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
CHEMBL1199009 14104 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
127045708 139550 0 None -3981 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 7 1 7 4.7 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3800513 139550 0 None -3981 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 7 1 7 4.7 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
46236661 8490 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
CHEMBL1094699 8490 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
24851766 105309 0 None -269 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126634 105309 0 None -269 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
44218479 139471 0 None -436 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)cc(C(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800001 139471 0 None -436 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)cc(C(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11495124 103959 0 None -812 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)cc2Cl)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103663 103959 0 None -812 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)cc2Cl)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
59593534 104237 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 410 7 1 3 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1CCC(=O)O 10.1021/jm4014373
CHEMBL3105486 104237 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 410 7 1 3 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1CCC(=O)O 10.1021/jm4014373
25182754 151690 0 None -4 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 347 4 2 5 4.0 O=C(Nc1ccnc2ccccc12)c1cc(NC2CCCCC2)ncn1 nan
CHEMBL3968786 151690 0 None -4 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 347 4 2 5 4.0 O=C(Nc1ccnc2ccccc12)c1cc(NC2CCCCC2)ncn1 nan
76310993 105273 0 None -97 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(N(CC)CC)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126598 105273 0 None -97 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(N(CC)CC)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46236663 8441 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 432 5 1 6 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(OC)c1 10.1021/jm100181s
CHEMBL1094246 8441 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 432 5 1 6 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(OC)c1 10.1021/jm100181s
67351486 105052 0 None -1949 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 12 3 6 3.8 Cc1cc(CCC(=O)c2sc(C)c(CC(C)C)c2C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121962 105052 0 None -1949 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 12 3 6 3.8 Cc1cc(CCC(=O)c2sc(C)c(CC(C)C)c2C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
76336213 105082 0 None -1096 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 11 3 6 3.8 CCc1cc(CCC(=O)c2scc3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121993 105082 0 None -1096 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 11 3 6 3.8 CCc1cc(CCC(=O)c2scc3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
25110382 145576 0 None -33113 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 366 6 1 6 4.2 CCOc1ccc(-c2nc(-c3cccc4c3CCC4O)no2)cc1OCC nan
CHEMBL3919445 145576 0 None -33113 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 366 6 1 6 4.2 CCOc1ccc(-c2nc(-c3cccc4c3CCC4O)no2)cc1OCC nan
23729229 105057 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3scc(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121967 105057 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3scc(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46237177 8835 0 None 2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2cccc(OCCO)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097802 8835 0 None 2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2cccc(OCCO)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
46237051 8833 0 None 1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 6 1 4 4.5 CC(C)/N=C1\S/C(=C\c2ccc(CCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097800 8833 0 None 1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 6 1 4 4.5 CC(C)/N=C1\S/C(=C\c2ccc(CCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
44565716 179163 0 None -25 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL474418 179163 0 None -25 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565717 188939 0 None -7 4 Human 7.3 pEC50 = 7.3 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL514170 188939 0 None -7 4 Human 7.3 pEC50 = 7.3 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
53317713 57687 0 None -5 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672555 57687 0 None -5 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
53326037 57097 0 None -1 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cnc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651856 57097 0 None -1 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cnc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
127046742 139397 0 None -50 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 12 3 9 3.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCC2)n1 10.1016/j.ejmech.2016.03.020
CHEMBL3799580 139397 0 None -50 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 12 3 9 3.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCC2)n1 10.1016/j.ejmech.2016.03.020
56949141 147604 0 None -48 2 Human 6.3 pEC50 = 6.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1ncccc1-c1noc(CCC2(c3ccccc3)CCCCC2)n1 nan
CHEMBL3935426 147604 0 None -48 2 Human 6.3 pEC50 = 6.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1ncccc1-c1noc(CCC2(c3ccccc3)CCCCC2)n1 nan
127046323 139484 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 11 3 8 2.8 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800093 139484 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 11 3 8 2.8 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11854857 104234 0 None -616 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(=O)CO 10.1021/jm4014373
CHEMBL3105483 104234 0 None -616 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(=O)CO 10.1021/jm4014373
57394329 70352 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 461 7 2 5 5.4 O=C(O)CCC(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950567 70352 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 461 7 2 5 5.4 O=C(O)CCC(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
66931911 139070 0 None -56 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCc1cc(-c2noc(-c3ccc(CN(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797436 139070 0 None -56 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCc1cc(-c2noc(-c3ccc(CN(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
127048142 139302 0 None -173 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 13 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)nc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799026 139302 0 None -173 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 13 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)nc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
70681813 74922 0 None -69 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 451 4 2 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(CN)c21 10.1021/ml200252b
CHEMBL2037122 74922 0 None -69 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 451 4 2 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(CN)c21 10.1021/ml200252b
46881537 7244 0 None -169 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 475 12 3 7 2.4 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc(S(=O)(=O)NCCC(=O)O)cc2C)ncn1 nan
CHEMBL1086157 7244 0 None -169 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 475 12 3 7 2.4 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc(S(=O)(=O)NCCC(=O)O)cc2C)ncn1 nan
11854356 104210 0 None -169 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 9 1 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNS(C)(=O)=O 10.1021/jm4014373
CHEMBL3105246 104210 0 None -169 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 9 1 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNS(C)(=O)=O 10.1021/jm4014373
118716142 114378 0 None -61 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 6 3.4 NC(CO)(CCc1ccc(-c2coc(-c3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341920 114378 0 None -61 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 6 3.4 NC(CO)(CCc1ccc(-c2coc(-c3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11852233 105079 0 None -467 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 12 3 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNCCC(=O)O 10.1021/jm401456d
CHEMBL3121990 105079 0 None -467 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 12 3 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNCCC(=O)O 10.1021/jm401456d
44217169 139337 0 None -44 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(CN(C)CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799260 139337 0 None -44 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(CN(C)CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
76321897 105303 0 None -64 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126628 105303 0 None -64 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
46237046 8805 0 None 1 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 3 0 3 4.9 Cc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
CHEMBL1097526 8805 0 None 1 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 3 0 3 4.9 Cc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
46237050 8846 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 366 5 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097843 8846 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 366 5 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236268 8920 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.3 CCC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098447 8920 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.3 CCC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
59202018 105053 0 None -75 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 447 12 3 6 3.2 Cc1cc(CCC(=O)c2ccc(CC(C)C)s2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121963 105053 0 None -75 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 447 12 3 6 3.2 Cc1cc(CCC(=O)c2ccc(CC(C)C)s2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
57570497 87166 0 None -2951 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 490 10 2 4 6.6 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C)c1 10.1021/ml300396r
CHEMBL2336067 87166 0 None -2951 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 490 10 2 4 6.6 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C)c1 10.1021/ml300396r
44625666 87182 0 None -331 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 5 5.9 C/C(=N\OCc1ccc(-c2cccs2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336084 87182 0 None -331 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 5 5.9 C/C(=N\OCc1ccc(-c2cccs2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
56948781 145118 0 None -17 2 Human 5.2 pEC50 = 5.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1F nan
CHEMBL3915834 145118 0 None -17 2 Human 5.2 pEC50 = 5.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1F nan
76336363 105291 0 None -630 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3ccc(N(CC)CC)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126616 105291 0 None -630 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3ccc(N(CC)CC)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11853834 104232 0 None -398 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 11 3 6 4.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCC(=O)O 10.1021/jm4014373
CHEMBL3105481 104232 0 None -398 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 11 3 6 4.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCC(=O)O 10.1021/jm4014373
57508868 105070 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 9 2 5 4.6 CCc1sc(C(=O)CCc2cc(C)c(OCC(O)CO)c(C)c2)c2c1CC(C)CC2 10.1021/jm401456d
CHEMBL3121981 105070 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 9 2 5 4.6 CCc1sc(C(=O)CCc2cc(C)c(OCC(O)CO)c(C)c2)c2c1CC(C)CC2 10.1021/jm401456d
10904818 300 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
2937 300 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
CHEMBL382739 300 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
118707195 112543 0 None -21 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 453 12 3 5 3.7 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(F)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311350 112543 0 None -21 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 453 12 3 5 3.7 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(F)c2)cc1 10.1016/j.bmc.2014.05.035
57400521 70581 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)c(C)c2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951319 70581 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)c(C)c2)n1 10.1016/j.bmcl.2011.12.019
53318790 57688 0 None -8 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.2 O=C(O)C1CN(Cc2ccc(-c3cn4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672556 57688 0 None -8 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.2 O=C(O)C1CN(Cc2ccc(-c3cn4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
118716181 114402 0 None -28 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 7 2.7 NC(CO)(CCc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342006 114402 0 None -28 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 7 2.7 NC(CO)(CCc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
44199450 105300 0 None -295 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cnc(N(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126625 105300 0 None -295 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cnc(N(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76318198 105290 0 None -3090 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)c(N(CC)CC)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126615 105290 0 None -3090 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)c(N(CC)CC)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25154344 6462 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1082869 6462 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
25154344 6462 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1082869 6462 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
76325392 105069 0 None -154 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 470 9 2 5 5.5 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CCCC1)CC2 10.1021/jm401456d
CHEMBL3121980 105069 0 None -154 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 470 9 2 5 5.5 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CCCC1)CC2 10.1021/jm401456d
11682696 79535 0 None -562 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 396 8 1 6 4.5 COc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
CHEMBL212580 79535 0 None -562 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 396 8 1 6 4.5 COc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
46846915 139483 0 None -15848 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 450 7 1 7 4.1 CC(C)Cc1onc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)c1C(F)(F)F 10.1021/acs.jmedchem.6b00089
CHEMBL3800091 139483 0 None -15848 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 450 7 1 7 4.1 CC(C)Cc1onc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)c1C(F)(F)F 10.1021/acs.jmedchem.6b00089
11568129 103924 0 None -776 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3102993 103924 0 None -776 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
56835182 69540 0 None -30 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938934 69540 0 None -30 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
44565597 178707 0 None -6 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473156 178707 0 None -6 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
56948659 153536 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysisAgonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysis
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL3984700 153536 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysisAgonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysis
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 10.1021/acs.jmedchem.6b01575
56948659 153536 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 nan
CHEMBL3984700 153536 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 nan
127046130 139385 0 None -144 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 402 6 1 7 3.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)on4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3799501 139385 0 None -144 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 402 6 1 7 3.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)on4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
54756908 65634 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 434 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)C4)no2)cc1C#N 10.1021/jm200609t
CHEMBL1836214 65634 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 434 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)C4)no2)cc1C#N 10.1021/jm200609t
44129140 115922 0 None -251 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 376 4 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360368 115922 0 None -251 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 376 4 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1C#N 10.1021/jm5010336
46881877 7026 0 None -9 4 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 359 13 2 5 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCc2nnn[nH]2)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1085191 7026 0 None -9 4 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 359 13 2 5 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCc2nnn[nH]2)cc1 10.1016/j.bmcl.2010.01.118
72793811 104213 0 None -93 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
CHEMBL3105249 104213 0 None -93 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
72793822 104229 0 None -15 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3105478 104229 0 None -15 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
66829256 139482 0 None -741 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800086 139482 0 None -741 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
25182913 147767 0 None -34 2 Human 6.2 pEC50 = 6.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 378 6 2 5 4.0 CC(C)CN(c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1)C1CCCC1 nan
CHEMBL3936796 147767 0 None -34 2 Human 6.2 pEC50 = 6.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 378 6 2 5 4.0 CC(C)CN(c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1)C1CCCC1 nan
46237048 8807 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
CHEMBL1097528 8807 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
11405953 63098 0 None -44 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 13 2 3 4.6 O=C(O)CCNC/C=C/c1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
CHEMBL1797499 63098 0 None -44 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 13 2 3 4.6 O=C(O)CCNC/C=C/c1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
76336569 105601 0 None -9 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 435 13 4 4 3.5 CCCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133606 105601 0 None -9 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 435 13 4 4 3.5 CCCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46236665 8443 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1Cc1ccccc1 10.1021/jm100181s
CHEMBL1094248 8443 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1Cc1ccccc1 10.1021/jm100181s
53320088 57686 0 None -52 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672554 57686 0 None -52 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
46237052 8710 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 7 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(OCCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096676 8710 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 7 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(OCCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46846899 139416 0 None -2511 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 9 1 7 4.9 CCCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3799701 139416 0 None -2511 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 9 1 7 4.9 CCCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
53322735 57691 0 None -33 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672559 57691 0 None -33 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
49872066 139280 0 None -95 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 11 3 9 3.6 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798839 139280 0 None -95 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 11 3 9 3.6 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
72793822 104229 0 None -15 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
CHEMBL3105478 104229 0 None -15 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
45377797 83701 0 None -288 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 456 11 2 6 4.4 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207777 83701 0 None -288 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 456 11 2 6 4.4 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
76329075 105279 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126604 105279 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
127046548 139073 0 None -234 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797447 139073 0 None -234 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
49872065 139100 0 None -117 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797626 139100 0 None -117 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
44599687 70347 0 None -194 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 5.9 O=C(O)CCCNc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950562 70347 0 None -194 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 5.9 O=C(O)CCCNc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
23121435 63100 0 None -301 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 387 12 2 3 4.8 O=C(O)CCNC/C=C/c1ccc(OCCCCc2ccccc2)cc1Cl 10.1016/j.bmcl.2011.05.029
CHEMBL1797501 63100 0 None -301 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 387 12 2 3 4.8 O=C(O)CCNC/C=C/c1ccc(OCCCCc2ccccc2)cc1Cl 10.1016/j.bmcl.2011.05.029
11397995 87167 0 None -10232 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 504 11 2 4 6.8 CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CNCCC(=O)O 10.1021/ml300396r
CHEMBL2336068 87167 0 None -10232 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 504 11 2 4 6.8 CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CNCCC(=O)O 10.1021/ml300396r
46846900 139065 0 None -1288 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 8 1 7 4.8 CC(C)Cc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3797415 139065 0 None -1288 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 8 1 7 4.8 CC(C)Cc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
76325522 105254 0 None -7413 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126433 105254 0 None -7413 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
16657820 105056 0 None -147 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 8 3.7 Cc1cc(-c2noc(-c3sc(C)c(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121966 105056 0 None -147 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 8 3.7 Cc1cc(-c2noc(-c3sc(C)c(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
57390144 69538 0 None -2 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 457 5 1 6 3.8 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C(=O)N5CCSC5)cc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1938932 69538 0 None -2 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 457 5 1 6 3.8 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C(=O)N5CCSC5)cc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
11853832 103915 0 None -1548 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 471 11 3 6 4.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCCO 10.1021/jm4014373
CHEMBL3102984 103915 0 None -1548 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 471 11 3 6 4.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCCO 10.1021/jm4014373
76325532 105280 0 None -3801 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126605 105280 0 None -3801 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25182920 143696 0 None -16 2 Human 6.1 pEC50 = 6.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 465 11 2 7 3.9 COC(=O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
CHEMBL3904549 143696 0 None -16 2 Human 6.1 pEC50 = 6.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 465 11 2 7 3.9 COC(=O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
11853337 104240 0 None -301 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.4 CNCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105489 104240 0 None -301 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.4 CNCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
23121338 63106 0 None -134 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 379 11 2 3 4.5 O=C(O)CCNCC1=Cc2ccc(OCCCCc3ccccc3)cc2CC1 10.1016/j.bmcl.2011.05.029
CHEMBL1797507 63106 0 None -134 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 379 11 2 3 4.5 O=C(O)CCNCC1=Cc2ccc(OCCCCc3ccccc3)cc2CC1 10.1016/j.bmcl.2011.05.029
44125588 115896 0 None -158 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 429 5 2 7 3.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(C(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359850 115896 0 None -158 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 429 5 2 7 3.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(C(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
70694328 74636 0 None -1995 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 466 6 1 4 5.7 O=C(O)C1CN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032440 74636 0 None -1995 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 466 6 1 4 5.7 O=C(O)C1CN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44128987 115893 0 None -1000 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 460 8 1 7 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCCC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359847 115893 0 None -1000 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 460 8 1 7 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCCC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
44128745 115917 0 None -3981 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 374 4 1 6 3.8 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNCC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360363 115917 0 None -3981 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 374 4 1 6 3.8 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNCC4)no2)cc1C#N 10.1021/jm5010336
44125469 115930 0 None -25 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 7 1 6 4.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360376 115930 0 None -25 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 7 1 6 4.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
44217502 139448 0 None -7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 538 14 3 8 3.8 CCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3799888 139448 0 None -7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 538 14 3 8 3.8 CCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
76314474 105091 0 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 10 3 8 4.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3122001 105091 0 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 10 3 8 4.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
45376041 83709 0 None -36 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.6 CC(C)CCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207785 83709 0 None -36 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.6 CC(C)CCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
57398468 70551 0 None -123 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 6 1 7 5.7 O=C(O)C1CN(Cc2cc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951147 70551 0 None -123 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 6 1 7 5.7 O=C(O)C1CN(Cc2cc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
127046399 139113 0 None -1122 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797747 139113 0 None -1122 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
24957029 8739 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.2 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096872 8739 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.2 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
127048102 139383 0 None -181 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(CN(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799493 139383 0 None -181 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(CN(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
76314473 105068 0 None -741 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.7 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CC2)CC1 10.1021/jm401456d
CHEMBL3121979 105068 0 None -741 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.7 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CC2)CC1 10.1021/jm401456d
56835064 71151 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935587 71151 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962536 71151 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
53235405 144561 0 None -6760 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2onc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
CHEMBL3911661 144561 0 None -6760 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2onc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
46236402 8511 0 None -14 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 4 1 4 3.9 C=CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094831 8511 0 None -14 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 4 1 4 3.9 C=CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
118716153 114390 0 None -15 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 450 10 4 6 2.8 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341931 114390 0 None -15 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 450 10 4 6 2.8 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46886019 8149 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 457 10 4 5 4.2 Cc1ccc(Oc2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1021/jm901776q
CHEMBL1092284 8149 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 457 10 4 5 4.2 Cc1ccc(Oc2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1021/jm901776q
76314472 105064 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 10 3 9 3.7 CCc1cc(-c2noc(-c3sc(OC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121975 105064 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 10 3 9 3.7 CCc1cc(-c2noc(-c3sc(OC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
57399546 70353 0 None -1380 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950568 70353 0 None -1380 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
44600643 57105 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 501 6 1 5 6.3 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCCCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651864 57105 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 501 6 1 5 6.3 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCCCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
11853579 103914 0 None -616 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 11 2 5 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCCO 10.1021/jm4014373
CHEMBL3102983 103914 0 None -616 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 11 2 5 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCCO 10.1021/jm4014373
118716147 114383 0 None -19 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 6 3.7 CCCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341925 114383 0 None -19 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 6 3.7 CCCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
59446831 144811 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 500 11 2 7 3.9 O=C(O)CCCS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
CHEMBL3913491 144811 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 500 11 2 7 3.9 O=C(O)CCCS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
46846913 139149 0 None -2818 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 424 9 1 7 4.1 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1CC(C)C 10.1021/acs.jmedchem.6b00089
CHEMBL3797951 139149 0 None -2818 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 424 9 1 7 4.1 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1CC(C)C 10.1021/acs.jmedchem.6b00089
67168742 144228 0 None -3235 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 520 5 2 7 5.0 N#CC1(NC(=O)C(O)c2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)CC1 nan
CHEMBL3909064 144228 0 None -3235 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 520 5 2 7 5.0 N#CC1(NC(=O)C(O)c2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)CC1 nan
11852636 105097 0 None -1380 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 399 7 1 4 5.3 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCN 10.1021/jm401456d
CHEMBL3122007 105097 0 None -1380 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 399 7 1 4 5.3 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCN 10.1021/jm401456d
46237049 8808 0 None 4 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097529 8808 0 None 4 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
76336362 105289 0 None -1071 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126614 105289 0 None -1071 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76314624 105294 0 None -4365 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126619 105294 0 None -4365 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76314623 105267 0 None -2187 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 4 9 2.3 CCNc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126591 105267 0 None -2187 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 4 9 2.3 CCNc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
118716150 114386 0 None -17 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 424 9 4 7 2.8 NC(CO)(CCc1ccc(-c2coc(-c3cccs3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341928 114386 0 None -17 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 424 9 4 7 2.8 NC(CO)(CCc1ccc(-c2coc(-c3cccs3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
72793791 104239 0 None -257 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 7 1 4 4.9 CNC(=O)COc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105488 104239 0 None -257 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 7 1 4 4.9 CNC(=O)COc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
127048141 139255 0 None -102 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
CHEMBL3798697 139255 0 None -102 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
11853836 104238 0 None -1445 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 7 1 4 4.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(N)=O 10.1021/jm4014373
CHEMBL3105487 104238 0 None -1445 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 7 1 4 4.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(N)=O 10.1021/jm4014373
53319458 57099 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651858 57099 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
11589375 103918 0 None -338 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 398 7 1 4 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCO 10.1021/jm4014373
CHEMBL3102987 103918 0 None -338 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 398 7 1 4 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCO 10.1021/jm4014373
46236404 8873 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
CHEMBL1098142 8873 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
46238365 8727 0 None -8 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 344 2 1 4 4.2 C/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096787 8727 0 None -8 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 344 2 1 4 4.2 C/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
58344592 154029 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
CHEMBL3921214 154029 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
CHEMBL3991184 154029 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
44600476 57102 6 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1651861 57102 6 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
44600476 57102 6 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.12.073
CHEMBL1651861 57102 6 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.12.073
44600476 57102 6 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651861 57102 6 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
52938426 3324 8 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
9889 3324 8 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
CHEMBL3899384 3324 8 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
58344778 154000 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
CHEMBL3902160 154000 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
CHEMBL3990889 154000 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
118716152 114389 0 None -34 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 462 11 4 7 2.7 COc1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341930 114389 0 None -34 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 462 11 4 7 2.7 COc1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
44591264 179399 0 None -7 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
CHEMBL474688 179399 0 None -7 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
11977818 70557 0 None -891 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)s2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951154 70557 0 None -891 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)s2)C1 10.1016/j.bmcl.2011.12.019
57397196 69541 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 499 6 1 6 4.8 CC(C)C1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938935 69541 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 499 6 1 6 4.8 CC(C)C1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
11484624 58134 0 None -3 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 341 12 2 3 3.7 O=C(O)CCNCCCc1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683042 58134 0 None -3 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 341 12 2 3 3.7 O=C(O)CCNCCCc1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
127047779 139170 0 None -30 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798098 139170 0 None -30 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44217168 139287 0 None -64 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(CN(C)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798876 139287 0 None -64 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(CN(C)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
127047084 139254 0 None -645 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798690 139254 0 None -645 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
58537193 139343 0 None -5370 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 416 6 1 7 3.9 Cc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
CHEMBL3799276 139343 0 None -5370 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 416 6 1 7 3.9 Cc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
46883880 7936 0 None -67 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1090758 7936 0 None -67 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
118716156 114393 0 None -6 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 474 11 4 6 3.8 CC(C)c1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341934 114393 0 None -6 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 474 11 4 6 3.8 CC(C)c1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
127046567 139473 0 None -933 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)cc(OC4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800028 139473 0 None -933 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)cc(OC4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11603726 76477 0 None -6760 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL206940 76477 0 None -6760 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
70686052 74928 0 None -234 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 494 6 2 4 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CCC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037128 74928 0 None -234 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 494 6 2 4 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CCC(=O)O)cc21 10.1021/ml200252b
57402282 71317 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935584 71317 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963634 71317 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
46236807 8972 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098811 8972 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
127046184 139350 0 None -478 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 484 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)nc(OC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799305 139350 0 None -478 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 484 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)nc(OC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11697013 77872 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL210695 77872 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
58390929 83715 0 None -870 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 498 9 1 6 5.1 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2C)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207792 83715 0 None -870 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 498 9 1 6 5.1 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2C)s1 10.1016/j.bmcl.2012.09.110
11697013 77872 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210695 77872 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
46236269 8921 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 2 1 4 5.3 CC(C)(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098448 8921 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 2 1 4 5.3 CC(C)(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
49871977 139520 0 None -239 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800336 139520 0 None -239 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
46195606 148779 0 None -40 2 Human 7.0 pEC50 = 7.0 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 450 10 3 7 3.4 CCCc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1CCC nan
CHEMBL3944892 148779 0 None -40 2 Human 7.0 pEC50 = 7.0 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 450 10 3 7 3.4 CCCc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1CCC nan
53326886 57695 0 None -32 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)c(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672563 57695 0 None -32 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)c(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
46884020 8355 0 None -30 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1093686 8355 0 None -30 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
2924 1610 37 None -10 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
44398069 1610 37 None -10 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
9908268 1610 37 None -10 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
CHEMBL114606 1610 37 None -10 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
118716154 114391 0 None -54 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 466 10 4 6 3.3 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341932 114391 0 None -54 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 466 10 4 6 3.3 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
57402358 69534 0 None -19 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
CHEMBL1938927 69534 0 None -19 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
46236808 8521 0 None 2 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 1 4 4.4 CC(C)/N=C1\S/C(=C\c2ccc(O)c(F)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094885 8521 0 None 2 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 1 4 4.4 CC(C)/N=C1\S/C(=C\c2ccc(O)c(F)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
52938427 2936 47 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
5383 2936 47 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
8709 2936 47 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
CHEMBL3707247 2936 47 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
DB12612 2936 47 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
46224769 199158 0 None -501 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 331 2 1 3 4.3 Cc1nn(C(=O)/C=C/c2cccc3[nH]ccc23)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL601062 199158 0 None -501 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 331 2 1 3 4.3 Cc1nn(C(=O)/C=C/c2cccc3[nH]ccc23)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
76318195 105276 0 None -4786 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126601 105276 0 None -4786 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
53323420 57100 0 None -26 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651859 57100 0 None -26 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
44607576 47844 0 None -25 3 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 391 5 1 4 5.5 COc1cccc(OC)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1550998 47844 0 None -25 3 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 391 5 1 4 5.5 COc1cccc(OC)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
5038554 45926 6 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 318 4 1 3 4.3 Cc1ccc(NC(=O)C(C)c2ccc([N+](=O)[O-])cc2)cc1Cl nan
CHEMBL1534431 45926 6 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 318 4 1 3 4.3 Cc1ccc(NC(=O)C(C)c2ccc([N+](=O)[O-])cc2)cc1Cl nan
16105531 168800 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL442040 168800 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
2727678 84096 34 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 287 11 2 3 4.0 CCCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
CHEMBL222029 84096 34 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 287 11 2 3 4.0 CCCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
3893874 33735 5 None 1 2 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 4 5.4 Cc1cc(C(=O)OC(C(=O)Nc2ccc(C)c(Cl)c2)c2ccccc2)c(C)o1 nan
CHEMBL1424117 33735 5 None 1 2 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 4 5.4 Cc1cc(C(=O)OC(C(=O)Nc2ccc(C)c(Cl)c2)c2ccccc2)c(C)o1 nan
3247435 45883 2 None 2 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 347 7 1 2 5.7 CCCC[C@@H]1C[C@H]1[C@@H](NC(=O)c1cccs1)c1ccc(Cl)cc1 nan
CHEMBL1533923 45883 2 None 2 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 347 7 1 2 5.7 CCCC[C@@H]1C[C@H]1[C@@H](NC(=O)c1cccs1)c1ccc(Cl)cc1 nan
44437393 14537 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
CHEMBL1206181 14537 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
CHEMBL239659 14537 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
10086559 118764 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1ccc(C2N[C@H](C(=O)O)CS2)cc1 10.1021/jm060834d
CHEMBL343684 118764 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1ccc(C2N[C@H](C(=O)O)CS2)cc1 10.1021/jm060834d
16105532 83655 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL220756 83655 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
1810026 19829 20 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 1 5.2 O=C(Nc1ccc(Br)cc1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1303503 19829 20 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 1 5.2 O=C(Nc1ccc(Br)cc1)C(c1ccccc1)c1ccccc1 nan
2727676 82761 4 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 273 10 2 3 3.6 CCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
CHEMBL218352 82761 4 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 273 10 2 3 3.6 CCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
44607582 35041 0 None -52 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 437 4 1 4 5.5 Cc1ccc(S(C)(=O)=O)c(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1436066 35041 0 None -52 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 437 4 1 4 5.5 Cc1ccc(S(C)(=O)=O)c(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
2328694 53446 2 None -11 5 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 408 6 2 3 5.2 O=C(Nc1ccccc1)Nc1cc(OCC(F)(F)F)cc(OCC(F)(F)F)c1 nan
CHEMBL1603615 53446 2 None -11 5 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 408 6 2 3 5.2 O=C(Nc1ccccc1)Nc1cc(OCC(F)(F)F)cc(OCC(F)(F)F)c1 nan
4492589 30692 7 None -251 4 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1397874 30692 7 None -251 4 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
2971621 43478 9 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 390 8 1 5 5.3 COc1ccc(C(CC(=O)c2ccc(C)cc2)Nc2ccc([N+](=O)[O-])cc2)cc1 nan
CHEMBL1510469 43478 9 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 390 8 1 5 5.3 COc1ccc(C(CC(=O)c2ccc(C)cc2)Nc2ccc([N+](=O)[O-])cc2)cc1 nan
3827421 33228 7 None -1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 329 4 1 1 5.8 O=C(Nc1ccc2ccccc2c1)C(c1ccccc1)C1CCCC1 nan
CHEMBL1419954 33228 7 None -1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 329 4 1 1 5.8 O=C(Nc1ccc2ccccc2c1)C(c1ccccc1)C1CCCC1 nan
11452022 3539 33 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
6996 3539 33 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
CHEMBL366208 3539 33 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
3730347 42695 7 None 2 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 293 4 1 1 4.9 Cc1ccc(NC(=O)C(c2ccccc2)C2CCCC2)cc1 nan
CHEMBL1503503 42695 7 None 2 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 293 4 1 1 4.9 Cc1ccc(NC(=O)C(c2ccccc2)C2CCCC2)cc1 nan
1363299 32724 10 None -100 5 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2ccc(Cl)cc2Cl)o1 nan
CHEMBL1415555 32724 10 None -100 5 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2ccc(Cl)cc2Cl)o1 nan
16105530 82778 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL218445 82778 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
6890484 72544 6 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 375 6 1 5 4.1 O=C(N/N=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)[C@H]1C[C@@H]1c1ccccc1 nan
CHEMBL2003667 72544 6 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 375 6 1 5 4.1 O=C(N/N=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)[C@H]1C[C@@H]1c1ccccc1 nan
2101118 39975 8 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 386 4 2 1 6.2 FC(F)(F)c1cccc(NC(S)=NC(c2ccccc2)c2ccccc2)c1 nan
CHEMBL1480424 39975 8 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 386 4 2 1 6.2 FC(F)(F)c1cccc(NC(S)=NC(c2ccccc2)c2ccccc2)c1 nan
6056442 78696 5 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 701 23 3 7 8.1 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)N2CCCCC2)cc1OC 10.1021/jm060834d
CHEMBL2113260 78696 5 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 701 23 3 7 8.1 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)N2CCCCC2)cc1OC 10.1021/jm060834d
16105541 82779 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL218446 82779 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
44419095 96218 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 743 27 4 7 10.2 CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
CHEMBL263827 96218 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 743 27 4 7 10.2 CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
564008 44992 12 None -1 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 333 4 0 5 4.5 O=[N+]([O-])c1ccc(C2=NN(c3ccccc3)C(c3ccco3)C2)cc1 nan
CHEMBL1526126 44992 12 None -1 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 333 4 0 5 4.5 O=[N+]([O-])c1ccc(C2=NN(c3ccccc3)C(c3ccco3)C2)cc1 nan
2353214 28855 7 None -3 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 387 6 1 2 5.7 O=C(Nc1ccc(OC(F)F)c(Cl)c1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1380914 28855 7 None -3 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 387 6 1 2 5.7 O=C(Nc1ccc(OC(F)F)c(Cl)c1)C(c1ccccc1)c1ccccc1 nan
2727242 39725 5 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 428 4 1 3 6.1 O=C(Nc1ccc(F)cc1F)c1c(C(F)(F)F)ccnc1Oc1ccc(Cl)cc1 nan
CHEMBL1478342 39725 5 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 428 4 1 3 6.1 O=C(Nc1ccc(F)cc1F)c1c(C(F)(F)F)ccnc1Oc1ccc(Cl)cc1 nan
44419094 96807 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 715 27 4 7 10.2 CCCCCCCCCCCCCCCCCNc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
CHEMBL268805 96807 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 715 27 4 7 10.2 CCCCCCCCCCCCCCCCCNc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
6217704 32367 3 None -14 6 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 490 7 0 8 5.2 CCOC(=O)/C(=C\c1ccc(OC(F)F)cc1)C1=Nn2c(nnc2-c2ccc(Cl)cc2)SC1 nan
CHEMBL1412583 32367 3 None -14 6 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 490 7 0 8 5.2 CCOC(=O)/C(=C\c1ccc(OC(F)F)cc1)C1=Nn2c(nnc2-c2ccc(Cl)cc2)SC1 nan
44437418 14660 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
CHEMBL1207343 14660 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
CHEMBL397081 14660 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
2233014 38729 9 None -3 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 429 7 1 6 4.9 COc1ccc(CC(=O)Nc2cccc(-c3nnc(-c4cccc(C)c4)o3)c2)cc1OC nan
CHEMBL1467999 38729 9 None -3 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 429 7 1 6 4.9 COc1ccc(CC(=O)Nc2cccc(-c3nnc(-c4cccc(C)c4)o3)c2)cc1OC nan
2810094 29370 4 None -1 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 3 4.9 Cc1cccc(Cn2nc(C(C)(C)C)cc2C(=O)Nc2ccc(F)cc2)c1 nan
CHEMBL1385499 29370 4 None -1 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 3 4.9 Cc1cccc(Cn2nc(C(C)(C)C)cc2C(=O)Nc2ccc(F)cc2)c1 nan
4841482 45820 6 None 2 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 3 5.3 Cc1ccc(NC(=O)C(OC(=O)c2ccc(F)cc2)c2ccccc2)cc1Cl nan
CHEMBL1533427 45820 6 None 2 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 3 5.3 Cc1ccc(NC(=O)C(OC(=O)c2ccc(F)cc2)c2ccccc2)cc1Cl nan
2794045 31354 9 None 1 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 279 4 1 1 4.6 O=C(Nc1ccccc1)C(c1ccccc1)C1CCCC1 nan
CHEMBL1404080 31354 9 None 1 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 279 4 1 1 4.6 O=C(Nc1ccccc1)C(c1ccccc1)C1CCCC1 nan
969623 199719 10 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 324 4 1 3 4.4 Cc1ccc(NC(=O)C2(c3ccc([N+](=O)[O-])cc3)CCCC2)cc1 nan
CHEMBL604664 199719 10 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 324 4 1 3 4.4 Cc1ccc(NC(=O)C2(c3ccc([N+](=O)[O-])cc3)CCCC2)cc1 nan
4168101 20667 5 None 1 2 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 405 5 1 3 5.5 O=C(OC(C(=O)Nc1cccc(C(F)(F)F)c1)c1ccccc1)C1CCCCC1 nan
CHEMBL1310437 20667 5 None 1 2 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 405 5 1 3 5.5 O=C(OC(C(=O)Nc1cccc(C(F)(F)F)c1)c1ccccc1)C1CCCCC1 nan
71450073 82177 0 None -234 4 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assayAntagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assay
ChEMBL 585 10 2 5 5.5 Cc1cc(S(=O)(=O)Nc2cccc(-c3cc(C)c(C(=O)N(C)[C@@H](CCN(C)C)C(=O)O)c(C)c3)c2)c(C)cc1Cl 10.1021/jm3009508
CHEMBL2178814 82177 0 None -234 4 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assayAntagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assay
ChEMBL 585 10 2 5 5.5 Cc1cc(S(=O)(=O)Nc2cccc(-c3cc(C)c(C(=O)N(C)[C@@H](CCN(C)C)C(=O)O)c(C)c3)c2)c(C)cc1Cl 10.1021/jm3009508
4460714 141428 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 442 18 2 4 6.5 CCCCCCCCCCCCCCCCOc1ccc(S(=O)(=O)O)cc1C(=O)O 10.1021/jm060834d
CHEMBL387252 141428 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 442 18 2 4 6.5 CCCCCCCCCCCCCCCCOc1ccc(S(=O)(=O)O)cc1C(=O)O 10.1021/jm060834d
3513763 22931 6 None -1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 413 5 1 3 5.8 Cc1ccc(NC(=O)C(OC(=O)c2ccccc2Cl)c2ccccc2)cc1Cl nan
CHEMBL1330917 22931 6 None -1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 413 5 1 3 5.8 Cc1ccc(NC(=O)C(OC(=O)c2ccccc2Cl)c2ccccc2)cc1Cl nan
9883039 31409 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1cccc(C2N[C@H](C(=O)O)CS2)c1 10.1021/jm060834d
CHEMBL140460 31409 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1cccc(C2N[C@H](C(=O)O)CS2)c1 10.1021/jm060834d
16105533 82780 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 664 23 3 6 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1 10.1021/jm060834d
CHEMBL218447 82780 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 664 23 3 6 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1 10.1021/jm060834d
44607575 52267 0 None -60 5 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 375 4 1 3 5.8 COc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1592119 52267 0 None -60 5 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 375 4 1 3 5.8 COc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
17253208 1272 45 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
9494 1272 45 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
CHEMBL1970071 1272 45 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
49869062 3600 0 None 28 2 Human 9.3 pA2 = 9.3 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 513 10 4 5 5.8 CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N 26494861
9493 3600 0 None 28 2 Human 9.3 pA2 = 9.3 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 513 10 4 5 5.8 CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N 26494861
44599207 3552 40 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
5326 3552 40 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
9289 3552 40 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
CHEMBL2336071 3552 40 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
DB12371 3552 40 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
52938427 2936 47 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
5383 2936 47 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
8709 2936 47 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
CHEMBL3707247 2936 47 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
DB12612 2936 47 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
11363176 3100 42 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
5446 3100 42 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
9320 3100 42 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
CHEMBL1096146 3100 42 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
107970 1609 76 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
2407 1609 76 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
4167 1609 76 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
CHEMBL314854 1609 76 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
DB08868 1609 76 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
49848557 1080 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
9492 1080 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
CHEMBL3769933 1080 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
44599207 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
5326 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
9289 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
CHEMBL2336071 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
DB12371 3552 40 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
16755143 499 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
9569 499 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
CHEMBL4297350 499 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
DB11819 499 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
11259583 520 12 None -1318 6 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
11259583 520 12 None -1318 6 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
2925 520 12 None -1318 6 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
2925 520 12 None -1318 6 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
CHEMBL4579553 520 12 None -1318 6 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
CHEMBL4579553 520 12 None -1318 6 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
11452022 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
6996 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
CHEMBL366208 3539 33 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
10904818 300 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
2937 300 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
CHEMBL382739 300 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
2924 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
2924 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
44398069 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
44398069 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
9908268 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
9908268 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
CHEMBL114606 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
CHEMBL114606 1610 37 None -10 6 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
10883396 3592 39 None -2 14 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
5283560 3592 39 None -2 14 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
911 3592 39 None -2 14 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
CHEMBL225155 3592 39 None -2 14 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
10883396 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
10883396 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
10883396 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
5283560 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
5283560 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
5283560 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
911 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
911 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
911 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
CHEMBL225155 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
CHEMBL225155 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
CHEMBL225155 3592 39 None 1 14 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
52938427 2936 47 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
5383 2936 47 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
8709 2936 47 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
CHEMBL3707247 2936 47 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
DB12612 2936 47 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
10282223 3947 3 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
2909 3947 3 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
CHEMBL327240 3947 3 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
2924 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
2924 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
44398069 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
44398069 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
9908268 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
9908268 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
CHEMBL114606 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
CHEMBL114606 1610 37 None -10 6 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
10430549 1032 33 None -2041 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743
2929 1032 33 None -2041 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743
CHEMBL194419 1032 33 None -2041 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743


Get vendors


Ligands Receptor Assay information Chemical information
Sel. page Common
name		 GPCRdb ID #Vendors Reference
ligand		 Fold selectivity
(Affinity)		 # tested GPCRs
(Affinity)		 Species p-value
(-log)		 Type Activity
Relation		 Activity
Value		 Assay Type Assay Description Source Mol
weight		 Rot
Bonds		 H don H acc LogP Smiles DOI
10883396 3592 39 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
5283560 3592 39 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
911 3592 39 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
CHEMBL225155 3592 39 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
10883396 3592 39 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
5283560 3592 39 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
911 3592 39 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
CHEMBL225155 3592 39 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
10883396 3592 39 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
5283560 3592 39 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
911 3592 39 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
CHEMBL225155 3592 39 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
49839234 117448 1 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human S1P3 receptor by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor by beta-arrestin recruitment assay
ChEMBL 472 6 3 3 6.1 O=C(O)CC1NCCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21 10.1016/j.bmcl.2014.11.089
CHEMBL3403619 117448 1 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human S1P3 receptor by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor by beta-arrestin recruitment assay
ChEMBL 472 6 3 3 6.1 O=C(O)CC1NCCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21 10.1016/j.bmcl.2014.11.089
25110488 71641 0 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 352 4 0 3 5.4 O=C(c1cc(-c2ccccc2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1973788 71641 0 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 352 4 0 3 5.4 O=C(c1cc(-c2ccccc2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
17253208 1272 45 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
9494 1272 45 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
CHEMBL1970071 1272 45 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
127031187 138353 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3781008 138353 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3782062 138353 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
67169586 181756 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01099
CHEMBL4784466 181756 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01099
76325531 105277 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126602 105277 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
67168053 180265 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 497 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4757149 180265 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 497 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
67169634 180411 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.6 Cc1cc2c(cc1CN1CC(C(=O)O)C1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL4758827 180411 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.6 Cc1cc2c(cc1CN1CC(C(=O)O)C1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F 10.1021/acs.jmedchem.6b01099
67170332 180091 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)sc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4755286 180091 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)sc2-3)C1 10.1021/acs.jmedchem.6b01099
162673462 182609 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.7 O=C(O)C1CN(Cc2ccc3c(c2)CCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4795734 182609 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.7 O=C(O)C1CN(Cc2ccc3c(c2)CCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
2924 1610 37 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
44398069 1610 37 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
9908268 1610 37 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
CHEMBL114606 1610 37 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
53235408 180293 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 473 5 1 6 4.7 CC1(c2onc(-c3onc4c3CCc3cc(CN5CC(C(=O)O)C5)ccc3-4)c2C(F)(F)F)CC1 10.1021/acs.jmedchem.6b01099
CHEMBL4757437 180293 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 473 5 1 6 4.7 CC1(c2onc(-c3onc4c3CCc3cc(CN5CC(C(=O)O)C5)ccc3-4)c2C(F)(F)F)CC1 10.1021/acs.jmedchem.6b01099
67171369 181109 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 496 5 1 7 4.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccn3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4776597 181109 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 496 5 1 7 4.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccn3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
162660222 180647 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4761456 180647 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
76321895 105282 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126607 105282 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
25110485 72418 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 5 0 3 5.0 CC(C)Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1999116 72418 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 5 0 3 5.0 CC(C)Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
67169708 181742 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2nsc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4784344 181742 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2nsc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
68182170 182449 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 448 8 1 6 4.4 CCOc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1OCC 10.1021/acs.jmedchem.6b01099
CHEMBL4793933 182449 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 448 8 1 6 4.4 CCOc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1OCC 10.1021/acs.jmedchem.6b01099
57391920 69543 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at S1P3 (unknown origin)Agonist activity at S1P3 (unknown origin)
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/acs.jmedchem.9b02092
CHEMBL1938937 69543 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at S1P3 (unknown origin)Agonist activity at S1P3 (unknown origin)
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/acs.jmedchem.9b02092
44342468 12012 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1184089 12012 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL332050 12012 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
162662293 180864 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 513 5 1 6 5.4 O=C(O)C1CN(Cc2cc3c(cc2F)-c2noc(-c4noc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4764300 180864 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 513 5 1 6 5.4 O=C(O)C1CN(Cc2cc3c(cc2F)-c2noc(-c4noc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 10.1021/acs.jmedchem.6b01099
46835922 138925 8 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3794064 138925 8 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b01099
68192004 182831 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4798447 182831 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
46835922 138925 8 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
CHEMBL3794064 138925 8 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
44398012 12158 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1184707 12158 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL364950 12158 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
162660222 180647 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4761456 180647 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
25110492 71581 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 302 4 0 3 4.3 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1972130 71581 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 302 4 0 3 4.3 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
162671724 182381 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4792990 182381 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
44398058 11661 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181660 11661 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL187712 11661 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110510 72322 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.5 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1995815 72322 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.5 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCC1 10.1016/j.bmcl.2013.09.075
162656217 180385 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
CHEMBL4758481 180385 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
52914984 147025 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3930827 147025 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
46847147 138797 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 431 7 1 8 3.5 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3792704 138797 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 431 7 1 8 3.5 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
127027154 137792 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 330 4 0 4 5.3 CC(C)Oc1ccc(-c2nnc(-c3ccccc3)s2)cc1Cl 10.1021/acs.jmedchem.5b01512
CHEMBL3771092 137792 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 330 4 0 4 5.3 CC(C)Oc1ccc(-c2nnc(-c3ccccc3)s2)cc1Cl 10.1021/acs.jmedchem.5b01512
2924 1610 37 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
44398069 1610 37 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
9908268 1610 37 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
CHEMBL114606 1610 37 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
25110496 71495 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.2 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1C 10.1016/j.bmcl.2013.09.075
CHEMBL1969371 71495 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.2 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1C 10.1016/j.bmcl.2013.09.075
77050638 139780 7 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 329 7 2 2 4.7 CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1 10.1021/acs.jmedchem.6b01433
CHEMBL3806158 139780 7 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 329 7 2 2 4.7 CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1 10.1021/acs.jmedchem.6b01433
67170391 179724 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 510 5 1 4 6.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2ccc(C3CCCCC3)c(C(F)(F)F)c2)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4750972 179724 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 510 5 1 4 6.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2ccc(C3CCCCC3)c(C(F)(F)F)c2)C1 10.1021/acs.jmedchem.6b01099
46847145 138853 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3793185 138853 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
162657458 180456 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 535 4 2 7 4.2 O=C1NC(=O)C2(CN(Cc3ccc4c(c3)CCc3c(-c5noc(-c6ccccc6)c5C(F)(F)F)noc3-4)C2)N1 10.1021/acs.jmedchem.6b01099
CHEMBL4759408 180456 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 535 4 2 7 4.2 O=C1NC(=O)C2(CN(Cc3ccc4c(c3)CCc3c(-c5noc(-c6ccccc6)c5C(F)(F)F)noc3-4)C2)N1 10.1021/acs.jmedchem.6b01099
86299710 118371 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3422425 118371 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
53234380 151882 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL3970572 151882 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
44398172 11674 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181739 11674 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL190529 11674 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
25110511 71704 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(c1cc(C2CC2)on1)N(C1CCCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1976353 71704 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(c1cc(C2CC2)on1)N(C1CCCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
67172039 148458 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL3942289 148458 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
25110501 71831 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 4 0 4 3.8 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1979798 71831 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 4 0 4 3.8 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
46835914 138929 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 471 6 1 8 4.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccn5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
CHEMBL3794145 138929 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 471 6 1 8 4.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccn5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
107970 1609 76 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
2407 1609 76 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
4167 1609 76 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
CHEMBL314854 1609 76 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
DB08868 1609 76 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
67171285 182719 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 481 5 1 6 5.1 O=C(O)C1CN(Cc2ccc3c(c2)Cc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4797042 182719 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 481 5 1 6 5.1 O=C(O)C1CN(Cc2ccc3c(c2)Cc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
25110484 71994 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 382 5 0 4 5.5 COc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1 10.1016/j.bmcl.2013.09.075
CHEMBL1984536 71994 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 382 5 0 4 5.5 COc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1 10.1016/j.bmcl.2013.09.075
11682677 11677 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181748 11677 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL190865 11677 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110498 72580 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 4 0 3 4.9 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL2004782 72580 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 4 0 3 4.9 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
56955982 103271 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.4 O=C(c1cc(C2CCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL3088204 103271 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.4 O=C(c1cc(C2CCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
25110494 71677 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 5 0 3 4.9 O=C(c1cc(C2CC2)on1)N(CC1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1975200 71677 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 5 0 3 4.9 O=C(c1cc(C2CC2)on1)N(CC1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
25110500 71458 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 4 3.5 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1967913 71458 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 4 3.5 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
156016628 177117 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL4641924 177117 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
118717778 114674 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 525 7 2 8 3.3 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)c4cccc(Cl)c4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
CHEMBL3344420 114674 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 525 7 2 8 3.3 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)c4cccc(Cl)c4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
76336361 105278 1 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126603 105278 1 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
118717777 114673 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 483 7 2 8 2.5 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)C4CCCC4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
CHEMBL3344419 114673 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 483 7 2 8 2.5 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)C4CCCC4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
5309153 37265 8 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1455786 37265 8 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
53235481 150610 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3959509 150610 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
67170089 179467 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c(-c4onc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4747682 179467 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c(-c4onc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
118717764 114659 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 481 7 2 8 2.3 CC1(C)CC(C(=O)N2CCN(c3noc(-c4cc(F)c(OC[C@@H](N)CO)cc4Cl)n3)CC2)C1 10.1016/j.bmcl.2014.09.003
CHEMBL3344405 114659 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 481 7 2 8 2.3 CC1(C)CC(C(=O)N2CCN(c3noc(-c4cc(F)c(OC[C@@H](N)CO)cc4Cl)n3)CC2)C1 10.1016/j.bmcl.2014.09.003
44342175 85095 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL227371 85095 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL422074 85095 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
67167161 181614 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2snc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4782854 181614 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2snc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
118717771 114667 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 509 7 2 8 2.5 CC(C)(C(=O)N1CCN(c2noc(-c3cc(F)c(OC[C@@H](N)CO)cc3Cl)n2)CC1)C(F)(F)F 10.1016/j.bmcl.2014.09.003
CHEMBL3344413 114667 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 509 7 2 8 2.5 CC(C)(C(=O)N1CCN(c2noc(-c3cc(F)c(OC[C@@H](N)CO)cc3Cl)n2)CC1)C(F)(F)F 10.1016/j.bmcl.2014.09.003
76311231 105598 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3133603 105598 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3780292 105598 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
11452022 3539 33 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
6996 3539 33 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
CHEMBL366208 3539 33 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
44392705 66333 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
9821227 66333 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL185389 66333 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL332472 66333 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
127031187 138353 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL3781008 138353 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL3782062 138353 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
25110499 71353 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.3 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1965004 71353 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.3 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCCC1 10.1016/j.bmcl.2013.09.075
56955980 103270 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 358 4 0 3 5.8 O=C(c1cc(C2CCCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL3088203 103270 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 358 4 0 3 5.8 O=C(c1cc(C2CCCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
44342246 11307 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL115505 11307 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1180159 11307 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
162656217 180385 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
CHEMBL4758481 180385 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
46847148 138848 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2ccccn2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1016/j.bmcl.2016.03.105
CHEMBL3793145 138848 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2ccccn2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1016/j.bmcl.2016.03.105
44398076 12791 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1188968 12791 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL537849 12791 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110212 103269 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 319 5 0 4 3.8 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccn1 10.1016/j.bmcl.2013.09.075
CHEMBL3088201 103269 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 319 5 0 4 3.8 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccn1 10.1016/j.bmcl.2013.09.075
3245758 27424 7 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 290 3 0 3 4.1 Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1369793 27424 7 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 290 3 0 3 4.1 Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
44398170 11667 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181688 11667 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL188826 11667 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
76329075 105279 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126604 105279 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
25110210 103213 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.4 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccc1 10.1016/j.bmcl.2013.09.075
CHEMBL3087666 103213 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.4 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccc1 10.1016/j.bmcl.2013.09.075
156013851 176621 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL4635110 176621 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
76325522 105254 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126433 105254 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
44342331 11311 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL116953 11311 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1180214 11311 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
162671724 182381 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4792990 182381 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
76325532 105280 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126605 105280 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
11675907 11671 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181694 11671 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL188881 11671 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
10883396 3592 39 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
5283560 3592 39 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
911 3592 39 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
CHEMBL225155 3592 39 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
44398049 13067 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1190950 13067 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL541890 13067 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
162652005 179721 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 361 12 3 3 4.2 CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1 10.1021/acs.jmedchem.6b01433
CHEMBL4750944 179721 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 361 12 3 3 4.2 CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1 10.1021/acs.jmedchem.6b01433
25110489 71688 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 304 5 0 3 4.3 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1975908 71688 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 304 5 0 3 4.3 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCC2)no1 10.1016/j.bmcl.2013.09.075
10883396 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
5283560 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
911 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
CHEMBL225155 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
10883396 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
5283560 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
911 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
CHEMBL225155 3592 39 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
72546270 103272 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 440 8 0 5 6.2 CCOc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1OCC 10.1016/j.bmcl.2013.09.075
CHEMBL3088205 103272 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 440 8 0 5 6.2 CCOc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1OCC 10.1016/j.bmcl.2013.09.075
46847146 138870 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 7 1 8 4.1 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3793394 138870 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 7 1 8 4.1 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
44342221 11987 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1183918 11987 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL324358 11987 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
44342244 64545 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL182164 64545 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL423691 64545 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
44342231 11994 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1183950 11994 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL325408 11994 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
10023913 12027 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1184130 12027 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL334038 12027 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
67172256 180592 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)oc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4760972 180592 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)oc2-3)C1 10.1021/acs.jmedchem.6b01099
11452022 3539 33 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
6996 3539 33 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
CHEMBL366208 3539 33 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
118717795 114336 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 547 9 3 9 2.2 N[C@H](COc1cc(Cl)c(-c2nc(N3CCN(C(=O)C4CCCC4)CC3)no2)cc1F)COP(=O)(O)O 10.1016/j.bmcl.2014.09.003
CHEMBL3341785 114336 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 547 9 3 9 2.2 N[C@H](COc1cc(Cl)c(-c2nc(N3CCN(C(=O)C4CCCC4)CC3)no2)cc1F)COP(=O)(O)O 10.1016/j.bmcl.2014.09.003
17253281 71482 9 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 3 4.9 CC(C)c1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1968913 71482 9 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 3 4.9 CC(C)c1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
76318195 105276 0 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126601 105276 0 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
10883396 3592 39 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
5283560 3592 39 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
911 3592 39 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
CHEMBL225155 3592 39 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
10883396 3592 39 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
5283560 3592 39 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
911 3592 39 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
CHEMBL225155 3592 39 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
44565597 178707 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473156 178707 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
10883396 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
5283560 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
911 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
CHEMBL225155 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
10883396 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
5283560 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
911 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
CHEMBL225155 3592 39 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
10883396 3592 39 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
5283560 3592 39 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
911 3592 39 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
CHEMBL225155 3592 39 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
10150171 167446 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL432067 167446 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
10150171 167446 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL432067 167446 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44159280 126410 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655496 126410 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44344390 13386 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 15 3 2 4.5 O=P(O)(O)CCCNCCCCCCCCCCc1ccccc1 10.1016/j.bmcl.2004.04.069
CHEMBL119349 13386 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 15 3 2 4.5 O=P(O)(O)CCCNCCCCCCCCCCc1ccccc1 10.1016/j.bmcl.2004.04.069
10883396 3592 39 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
5283560 3592 39 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
911 3592 39 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
CHEMBL225155 3592 39 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
10172546 113945 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 15 3 3 4.5 CCCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL333335 113945 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 15 3 3 4.5 CCCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10193915 14070 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 375 14 3 3 4.2 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1F 10.1016/j.bmcl.2004.04.070
CHEMBL119873 14070 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 375 14 3 3 4.2 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1F 10.1016/j.bmcl.2004.04.070
25059746 126321 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 9 1 3 7.1 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655408 126321 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 9 1 3 7.1 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10215138 13967 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 15 3 2 4.6 CCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119760 13967 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 15 3 2 4.6 CCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44159280 126410 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655496 126410 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762369 126416 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 5 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ncco1 nan
CHEMBL3655502 126416 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 5 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ncco1 nan
59762343 126425 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3cccnc3)cc2n1Cc1ccccn1 nan
CHEMBL3655510 126425 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3cccnc3)cc2n1Cc1ccccn1 nan
44565715 179861 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475253 179861 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
137651211 156783 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 339 13 2 2 5.0 CCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4077381 156783 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 339 13 2 2 5.0 CCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1021/acs.jmedchem.6b01575
44565596 188955 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514302 188955 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
11510741 189178 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 452 12 4 6 2.9 COc1ccc(CCCCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL516035 189178 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 452 12 4 6 2.9 COc1ccc(CCCCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
44344360 10150 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 339 14 3 3 4.8 CCCCCCCCCc1ccc(CNCCCP(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL1160958 10150 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 339 14 3 3 4.8 CCCCCCCCCc1ccc(CNCCCP(O)O)cc1 10.1016/j.bmcl.2004.04.069
44344338 13271 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 15 3 2 4.7 CCCCCCCc1ccc(CCCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119257 13271 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 15 3 2 4.7 CCCCCCCc1ccc(CCCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10173002 167542 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 15 3 4 4.4 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL432813 167542 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 15 3 4 4.4 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10195325 84696 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.9 O=C(O)C1CCN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
CHEMBL224799 84696 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.9 O=C(O)C1CCN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
10174255 84793 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
CHEMBL225575 84793 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
46885744 7679 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 548 10 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Br)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1089127 7679 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 548 10 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Br)c1 10.1016/j.bmcl.2010.02.098
138377599 180857 9 None - 0 Human 6.0 pIC50 = 6 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 408 5 0 5 5.1 CCC/N=C1\S/C(=C\c2ccc(OC(C)=O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
CHEMBL4764124 180857 9 None - 0 Human 6.0 pIC50 = 6 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 408 5 0 5 5.1 CCC/N=C1\S/C(=C\c2ccc(OC(C)=O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
44412232 165767 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 391 6 2 5 4.5 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](C(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
CHEMBL427221 165767 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 391 6 2 5 4.5 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](C(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
58907658 86143 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 350 13 3 4 3.6 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315815 86143 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 350 13 3 4 3.6 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
58907531 86144 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 364 13 3 4 3.9 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315816 86144 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 364 13 3 4 3.9 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11501417 86145 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 362 12 3 4 3.7 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)/C=C/C(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315817 86145 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 362 12 3 4 3.7 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)/C=C/C(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11408903 84702 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 7 1 4 6.1 Cc1cc(CN2CC(C(=O)O)C2)cc(C)c1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL224853 84702 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 7 1 4 6.1 Cc1cc(CN2CC(C(=O)O)C2)cc(C)c1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
11705484 178716 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc(-c3ccccc3)c2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473237 178716 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc(-c3ccccc3)c2)cc1 10.1016/j.bmcl.2009.02.073
44565713 179857 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3C#N)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475247 179857 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3C#N)cc2)cc1 10.1016/j.bmcl.2009.02.073
58907649 86142 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315814 86142 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
10287091 10501 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 4 3 4.1 CCCCCCCCC(O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL117007 10501 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 4 3 4.1 CCCCCCCCC(O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10309271 13247 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 14 4 4 3.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1O 10.1016/j.bmcl.2004.04.070
CHEMBL119239 13247 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 14 4 4 3.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1O 10.1016/j.bmcl.2004.04.070
44413349 77286 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208838 77286 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
44217417 125909 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 3 4 4.0 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
CHEMBL3651719 125909 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 3 4 4.0 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
59762441 126397 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 5 5.7 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN3CCCC3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655482 126397 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 5 5.7 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN3CCCC3)n(Cc3ccccn3)c2c1 nan
59762392 126364 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCC(C)(C)O3)cc2n1Cc1ccccc1 nan
CHEMBL3655450 126364 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCC(C)(C)O3)cc2n1Cc1ccccc1 nan
10430549 1032 33 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/ml100227q
2929 1032 33 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/ml100227q
CHEMBL194419 1032 33 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/ml100227q
25060001 126428 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.8 COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655513 126428 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.8 COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59504175 126439 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 4 6.8 CC(C)COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655525 126439 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 4 6.8 CC(C)COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44565621 178734 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 6 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2cccs2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473360 178734 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 6 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2cccs2)cc1 10.1016/j.bmcl.2009.02.073
59762314 126401 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 7 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655487 126401 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 7 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3)cc2n1Cc1ccccn1 nan
10236683 167528 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 319 14 2 2 4.9 CCCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL432632 167528 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 319 14 2 2 4.9 CCCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
137638716 156432 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 305 13 2 2 4.5 CCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4072987 156432 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 305 13 2 2 4.5 CCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1021/acs.jmedchem.6b01575
44233260 126448 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 442 9 1 5 5.3 CCCOc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655534 126448 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 442 9 1 5 5.3 CCCOc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394117 66009 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 17 2 2 6.1 CCCCCCCCCCCCCCC1CCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185066 66009 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 17 2 2 6.1 CCCCCCCCCCCCCCC1CCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
10430549 1032 33 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
2929 1032 33 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
CHEMBL194419 1032 33 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
10249887 70584 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 5 1 5 4.2 CC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL195141 70584 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 5 1 5 4.2 CC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
9979368 71362 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 417 6 1 5 5.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL196534 71362 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 417 6 1 5 5.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
10430549 1032 33 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
2929 1032 33 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
CHEMBL194419 1032 33 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
44233258 126449 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 456 9 1 5 5.6 CC(C)COc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655535 126449 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 456 9 1 5 5.6 CC(C)COc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
10151146 13100 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 425 14 3 3 5.4 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
CHEMBL119116 13100 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 425 14 3 3 5.4 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
44344210 13695 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 15 3 2 4.1 CCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119562 13695 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 15 3 2 4.1 CCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762430 126385 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655470 126385 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
59762388 126403 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655489 126403 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
10216035 10932 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 20 3 2 6.5 CCCCCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117569 10932 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 20 3 2 6.5 CCCCCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762287 126415 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCOCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655501 126415 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCOCC3)cc2n1Cc1ccccn1 nan
11743459 140260 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 431 7 1 5 4.4 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(CCC(F)(F)F)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL381872 140260 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 431 7 1 5 4.4 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(CCC(F)(F)F)cc4)n3)cc2)C1 10.1021/jm0503244
44234512 126895 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 5 5.4 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659693 126895 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 5 5.4 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
10125861 13089 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 16 3 2 5.0 CCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119110 13089 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 16 3 2 5.0 CCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344412 13243 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCc1ccc(CCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119233 13243 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCc1ccc(CCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
44232784 126331 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.9 CC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655418 126331 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.9 CC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44232786 126333 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)C(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655420 126333 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)C(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10408874 72145 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 403 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL198976 72145 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 403 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
59504166 126447 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 1 4 6.4 CCO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655533 126447 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 1 4 6.4 CCO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233495 126880 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 4 7.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/OC(C)(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3659678 126880 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 4 7.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/OC(C)(C)C)cc2n1Cc1ccccc1 nan
25060537 126433 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 2 3 6.2 CCCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655519 126433 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 2 3 6.2 CCCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233497 126882 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.4 CO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3659680 126882 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.4 CO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
21455530 10047 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 363 19 3 2 5.6 CCCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL115738 10047 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 363 19 3 2 5.6 CCCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762339 126369 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 479 8 2 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655455 126369 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 479 8 2 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)O)n(Cc3ccccn3)c2c1 nan
59762277 126391 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
CHEMBL3655476 126391 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
44234257 126893 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 9 1 4 6.2 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659691 126893 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 9 1 4 6.2 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44413430 138240 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 405 7 2 5 4.7 CC(C)Cc1ccc(-c2nc(-c3ccc([C@H]4C[C@@H](CC(=O)O)CN4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.090
CHEMBL378061 138240 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 405 7 2 5 4.7 CC(C)Cc1ccc(-c2nc(-c3ccc([C@H]4C[C@@H](CC(=O)O)CN4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.090
59762368 126400 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 2 4 6.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655485 126400 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 2 4 6.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccn1 nan
59762285 126380 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 5 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccc1 nan
CHEMBL3655466 126380 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 5 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccc1 nan
11555202 179151 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3Cl)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL474407 179151 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3Cl)cc2)cc1 10.1016/j.bmcl.2009.02.073
44234513 125906 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 382 8 3 3 4.1 O=P(O)(O)CCCNCc1ccc(-c2ccccc2)c(-c2ccccc2)n1 nan
CHEMBL3651716 125906 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 382 8 3 3 4.1 O=P(O)(O)CCCNCc1ccc(-c2ccccc2)c(-c2ccccc2)n1 nan
59762273 126357 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 2 5 5.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](CO)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655444 126357 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 2 5 5.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](CO)CO3)cc2n1Cc1ccccc1 nan
59762438 126406 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655492 126406 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59504167 125918 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 461 6 2 4 5.7 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccn2)c2ccc(O)cc12 nan
CHEMBL3651727 125918 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 461 6 2 4 5.7 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccn2)c2ccc(O)cc12 nan
59762397 126351 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 4 6.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655438 126351 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 4 6.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
59762381 126389 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1cccnc1 nan
CHEMBL3655474 126389 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1cccnc1 nan
44394149 123509 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 377 15 3 3 4.5 CCCCCCCCCCCCCCN1CCC(C(O)P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL363008 123509 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 377 15 3 3 4.5 CCCCCCCCCCCCCCN1CCC(C(O)P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
10308738 10174 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCC(O)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL116140 10174 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCC(O)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
10286857 167541 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 353 14 2 2 5.4 CCCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL432809 167541 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 353 14 2 2 5.4 CCCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1016/j.bmcl.2004.04.069
25060262 126429 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 3 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655515 126429 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 3 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N3CCCC3)cc2n1Cc1ccccc1 nan
44412416 77827 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 431 6 2 5 5.7 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL210520 77827 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 431 6 2 5 5.7 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
59762431 126374 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 433 6 2 3 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N)cc2n1Cc1ccccc1 nan
CHEMBL3655460 126374 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 433 6 2 3 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N)cc2n1Cc1ccccc1 nan
44233749 126885 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659683 126885 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762344 126375 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCOC3)cc2n1Cc1ccccc1 nan
CHEMBL3655461 126375 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCOC3)cc2n1Cc1ccccc1 nan
10384596 10041 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL115713 10041 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10384596 10041 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL115713 10041 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
59762383 126361 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cc(F)cc(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
CHEMBL3655448 126361 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cc(F)cc(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
44341276 10011 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115554 10011 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
10287034 65852 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184349 65852 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
10287365 10473 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 389 12 3 2 5.1 CCCCCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL116981 10473 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 389 12 3 2 5.1 CCCCCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2004.04.070
44234516 125908 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.2 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651718 125908 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.2 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
44234760 125911 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 3 4 3.6 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
CHEMBL3651720 125911 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 3 4 3.6 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
59504169 126446 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 455 8 1 5 5.3 CCOC(=O)c1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655532 126446 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 455 8 1 5 5.3 CCOC(=O)c1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762366 126418 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 8 1 5 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655504 126418 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 8 1 5 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
25059487 125903 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651713 125903 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059487 125903 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651713 125903 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234005 126887 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccn1 nan
CHEMBL3659685 126887 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccn1 nan
44394153 65825 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 363 14 3 3 4.3 CCCCCCCCCCCCCCN1CCC(O)(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL184237 65825 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 363 14 3 3 4.3 CCCCCCCCCCCCCCN1CCC(O)(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44394169 66350 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 2 2 5.7 CCCCCCCCCCCCCCN1CCCC1CCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185447 66350 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 2 2 5.7 CCCCCCCCCCCCCCN1CCCC1CCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44234763 125914 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 2 3 4.8 Cc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651723 125914 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 2 3 4.8 Cc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
127041987 136105 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 319 11 1 3 3.9 CCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3739878 136105 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 319 11 1 3 3.9 CCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
25060263 126430 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 7 1 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655516 126430 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 7 1 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N(C)C)cc2n1Cc1ccccc1 nan
44344456 10543 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 NC(CCCCCCCCCCc1ccccc1)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117031 10543 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 NC(CCCCCCCCCCc1ccccc1)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344404 11256 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 18 3 2 5.2 CCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117973 11256 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 18 3 2 5.2 CCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
11725751 12738 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
11725751 12738 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL118860 12738 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118860 12738 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10149985 13268 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL119256 13268 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
44394191 65977 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184879 65977 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
44344194 11811 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 16 3 2 4.5 CCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL118265 11811 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 16 3 2 4.5 CCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44394191 65977 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184879 65977 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
44565717 188939 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL514170 188939 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565738 189161 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL515917 189161 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565717 188939 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL514170 188939 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
44232785 126332 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.3 CCC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655419 126332 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.3 CCC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762446 126407 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655493 126407 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
10311227 168767 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 493 17 3 4 5.6 CCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL441826 168767 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 493 17 3 4 5.6 CCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
11540052 179985 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475405 179985 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11540052 179985 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL475405 179985 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
10217498 84662 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 481 7 1 4 6.2 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(Cl)c2)C1 10.1021/jm0492507
CHEMBL224571 84662 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 481 7 1 4 6.2 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(Cl)c2)C1 10.1021/jm0492507
46885742 7620 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C#N)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1088819 7620 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C#N)c1 10.1016/j.bmcl.2010.02.098
25008420 8379 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 547 9 4 5 5.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL1093823 8379 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 547 9 4 5 5.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1 10.1016/j.bmcl.2010.02.098
25060261 126343 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 2 3 5.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CO)cc2n1Cc1ccccc1 nan
CHEMBL3655430 126343 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 2 3 5.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CO)cc2n1Cc1ccccc1 nan
11224984 8629 18 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 8629 18 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
59504164 125917 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 418 6 1 2 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL3651726 125917 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 418 6 1 2 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccccc2n1Cc1ccccc1 nan
11725751 12738 5 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118860 12738 5 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10149985 13268 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL119256 13268 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
59762348 126370 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 5 5.3 CC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655456 126370 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 5 5.3 CC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
59762396 126423 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ccccn3)cc2n1Cc1ccccn1 nan
CHEMBL3655509 126423 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ccccn3)cc2n1Cc1ccccn1 nan
59504168 126442 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.0 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655528 126442 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.0 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
11683935 178761 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 456 9 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473563 178761 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 456 9 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
44565716 179163 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL474418 179163 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
10127776 10950 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117723 10950 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
44413415 138161 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 2 4 6.1 O=C(O)CC1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377855 138161 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 2 4 6.1 O=C(O)CC1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
10127776 10950 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1021/jm0492507
CHEMBL117723 10950 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1021/jm0492507
10215259 84683 5 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 331 11 1 2 4.9 CCCCCCCCCc1ccc(CN2CCC(C(=O)O)C2)cc1 10.1021/jm0492507
CHEMBL224703 84683 5 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 331 11 1 2 4.9 CCCCCCCCCc1ccc(CN2CCC(C(=O)O)C2)cc1 10.1021/jm0492507
11248292 142974 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 7 1 4 5.7 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(F)c2)C1 10.1021/jm0492507
CHEMBL389880 142974 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 7 1 4 5.7 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(F)c2)C1 10.1021/jm0492507
59762332 126393 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 495 7 1 3 7.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccc1 nan
CHEMBL3655478 126393 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 495 7 1 3 7.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccc1 nan
10287034 65852 3 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1021/jm0492507
CHEMBL184349 65852 3 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1021/jm0492507
44394330 65682 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 3 3 5.4 CCCCCCCCCCCCCCC1CC(O)(P(C)(=O)O)CCN1 10.1016/j.bmcl.2004.07.049
CHEMBL183688 65682 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 3 3 5.4 CCCCCCCCCCCCCCC1CC(O)(P(C)(=O)O)CCN1 10.1016/j.bmcl.2004.07.049
44394247 121702 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 3 2 6.0 CCCCCCCCCCCCCCNC1CCCCC1CP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL359762 121702 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 3 2 6.0 CCCCCCCCCCCCCCNC1CCCCC1CP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44412364 77749 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL210257 77749 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
127037695 136052 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 333 12 1 3 4.3 CCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3739440 136052 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 333 12 1 3 4.3 CCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762334 126420 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 586 8 1 7 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ncc(Br)s3)cc2n1Cc1ncco1 nan
CHEMBL3655506 126420 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 586 8 1 7 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ncc(Br)s3)cc2n1Cc1ncco1 nan
44233018 126436 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 2 3 6.5 CC(C)NCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655522 126436 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 2 3 6.5 CC(C)NCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234515 125907 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.4 Cc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651717 125907 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.4 Cc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
91203058 126344 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 461 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN=O)cc2n1Cc1ccccc1 nan
CHEMBL3655431 126344 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 461 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN=O)cc2n1Cc1ccccc1 nan
44232783 126329 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 7 1 4 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)N(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655416 126329 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 7 1 4 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)N(C)C)cc2n1Cc1ccccc1 nan
59762375 126337 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655424 126337 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762301 126340 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3cc(F)cc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655427 126340 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3cc(F)cc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762342 126426 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 9 1 5 5.9 CCOC(=O)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
CHEMBL3655511 126426 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 9 1 5 5.9 CCOC(=O)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
44233748 126884 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCNC3)cc2n1Cc1ccccc1 nan
CHEMBL3659682 126884 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCNC3)cc2n1Cc1ccccc1 nan
59762355 126338 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
CHEMBL3655425 126338 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
25059999 126326 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 10 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCCN(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655413 126326 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 10 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCCN(C)C)cc2n1Cc1ccccc1 nan
59762312 126373 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 7 1 4 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccc1 nan
CHEMBL3655459 126373 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 7 1 4 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccc1 nan
59762384 126355 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655442 126355 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
44412165 77408 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 77408 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
44565703 188941 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 444 9 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc3ccccc23)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514189 188941 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 444 9 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc3ccccc23)cc1 10.1016/j.bmcl.2009.02.073
44233019 126437 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 9 2 3 6.1 CCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655523 126437 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 9 2 3 6.1 CCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10310253 13395 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 435 14 3 3 4.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
CHEMBL119354 13395 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 435 14 3 3 4.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
10172513 10087 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 14 3 3 4.3 CCCCCCCCC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL115970 10087 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 14 3 3 4.3 CCCCCCCCC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
25059748 126323 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 524 9 1 3 7.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ccccc3)cc2n1Cc1ccccc1 nan
CHEMBL3655410 126323 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 524 9 1 3 7.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ccccc3)cc2n1Cc1ccccc1 nan
44159392 126438 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 10 2 3 6.5 CCCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655524 126438 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 10 2 3 6.5 CCCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233496 126881 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 1 4 6.8 CCO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3659679 126881 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 1 4 6.8 CCO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762325 126372 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 9 1 6 5.5 CO/N=C(/C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655458 126372 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 9 1 6 5.5 CO/N=C(/C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
44394220 66668 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL186921 66668 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44565714 178717 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473238 178717 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
10215741 10910 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 3 4 3.5 CCCCCCCOC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL117403 10910 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 3 4 3.5 CCCCCCCOC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10172338 110058 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL325198 110058 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
137655932 158411 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CC[C@@H](N)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4095976 158411 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CC[C@@H](N)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
59762427 126359 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 8 1 6 5.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ncco4)c3c2)=N1 nan
CHEMBL3655446 126359 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 8 1 6 5.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ncco4)c3c2)=N1 nan
10172338 110058 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL325198 110058 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
46885743 7621 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Cl)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1088820 7621 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Cl)c1 10.1016/j.bmcl.2010.02.098
44234004 126889 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 10 1 5 5.4 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659687 126889 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 10 1 5 5.4 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762421 126386 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 9 1 5 5.7 CC(C)COc1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655471 126386 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 9 1 5 5.7 CC(C)COc1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
57554674 136276 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 399 12 3 4 4.5 CCCCCCCCOc1ccc([C@@H]2CC[C@](N)(COP(=O)(O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3741414 136276 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 399 12 3 4 4.5 CCCCCCCCOc1ccc([C@@H]2CC[C@](N)(COP(=O)(O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
25059486 126320 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 10 1 3 7.2 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655407 126320 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 10 1 3 7.2 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25160863 126324 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 1 3 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655411 126324 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 1 3 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccc1 nan
44234003 126888 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3659686 126888 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
11725751 12738 5 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL118860 12738 5 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
44344193 114414 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL334213 114414 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344193 114414 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1021/jm0492507
CHEMBL334213 114414 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1021/jm0492507
44591264 179399 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
CHEMBL474688 179399 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
44344193 114414 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL334213 114414 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
10363915 134670 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 405 7 1 5 4.6 CCC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL372066 134670 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 405 7 1 5 4.6 CCC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
44394220 66668 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL186921 66668 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
59504172 125916 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 460 6 2 3 6.3 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccc2)c2ccc(O)cc12 nan
CHEMBL3651725 125916 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 460 6 2 3 6.3 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccc2)c2ccc(O)cc12 nan
44565622 178760 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473562 178760 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
44413447 138154 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 431 6 2 5 5.6 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377828 138154 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 431 6 2 5 5.6 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
25160740 126319 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1ccccc1 nan
CHEMBL3655406 126319 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1ccccc1 nan
25059747 126322 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 12 1 3 8.0 CCCCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655409 126322 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 12 1 3 8.0 CCCCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
49787250 125912 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 424 10 3 3 5.0 CCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651721 125912 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 424 10 3 3 5.0 CCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
24752909 125919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 410 9 3 3 4.6 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651728 125919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 410 9 3 3 4.6 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
44341466 9919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL114976 9919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44341291 10042 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115714 10042 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44234006 126890 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 4 5.4 C#CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659688 126890 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 4 5.4 C#CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
46885745 8325 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 484 10 4 5 4.0 Cc1cc(NC(=O)[C@@](C)(N)COP(=O)(O)O)ccc1OCCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL1093424 8325 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 484 10 4 5 4.0 Cc1cc(NC(=O)[C@@](C)(N)COP(=O)(O)O)ccc1OCCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.02.098
59762297 126352 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655439 126352 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
25060265 126432 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 2 3 5.8 CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655518 126432 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 2 3 5.8 CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
24804606 125915 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2cc(O)ccc2n1Cc1ccccc1 nan
CHEMBL3651724 125915 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2cc(O)ccc2n1Cc1ccccc1 nan
59762420 126349 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 8 1 5 5.8 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cncc(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655436 126349 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 8 1 5 5.8 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cncc(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
10125882 165032 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 337 14 2 2 4.9 CCCCCCCCCc1ccc(CNCC(F)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL424254 165032 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 337 14 2 2 4.9 CCCCCCCCCc1ccc(CNCC(F)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
59762303 126339 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 481 8 1 6 5.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655426 126339 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 481 8 1 6 5.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
59762418 126346 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 7 1 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCCO3)cc2n1Cc1ccccc1 nan
CHEMBL3655433 126346 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 7 1 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCCO3)cc2n1Cc1ccccc1 nan
59762298 126381 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655467 126381 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccc1 nan
59762305 126383 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 519 8 1 5 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655469 126383 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 519 8 1 5 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccn1 nan
44233017 126434 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 1 3 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655520 126434 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 1 3 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN3CCCC3)cc2n1Cc1ccccc1 nan
10125862 11520 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCCC(O)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118068 11520 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCCC(O)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
44394248 65917 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 361 15 3 2 5.4 CCCCCCCCCCCCCCNC1CCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL184591 65917 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 361 15 3 2 5.4 CCCCCCCCCCCCCCNC1CCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44565595 178691 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 476 10 4 6 3.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3cccs3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473016 178691 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 476 10 4 6 3.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3cccs3)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762320 126413 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 7 1 5 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccnn3C)cc2n1Cc1ccccn1 nan
CHEMBL3655499 126413 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 7 1 5 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccnn3C)cc2n1Cc1ccccn1 nan
59762432 126404 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655490 126404 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59762280 126422 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 507 8 1 5 6.6 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(OC4CCCC4)cc32)no1 nan
CHEMBL3655508 126422 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 507 8 1 5 6.6 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(OC4CCCC4)cc32)no1 nan
44412165 77408 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 77408 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
11503967 7939 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 482 10 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(C(=O)CCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL1090796 7939 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 482 10 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(C(=O)CCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
91433973 126371 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 6 5.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)N=O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655457 126371 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 6 5.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)N=O)n(Cc3ccccn3)c2c1 nan
44233016 126334 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 478 9 1 4 6.0 COCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655421 126334 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 478 9 1 4 6.0 COCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10193676 13627 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 2 2 5.2 CCCCCCCCCc1ccc(CNCCC(F)(F)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119516 13627 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 2 2 5.2 CCCCCCCCCc1ccc(CNCCC(F)(F)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
59762407 126414 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 514 7 1 5 6.7 Cc1noc(C)c1-c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655500 126414 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 514 7 1 5 6.7 Cc1noc(C)c1-c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762390 126366 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 6 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C3=NCCO3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655452 126366 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 6 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C3=NCCO3)n(Cc3ccccn3)c2c1 nan
59762449 126417 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 9 1 5 5.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655503 126417 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 9 1 5 5.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
25160865 126330 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 7 1 4 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)C(C)(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655417 126330 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 7 1 4 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)C(C)(C)C)cc2n1Cc1ccccc1 nan
25060538 126440 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 10 1 4 7.0 CCCCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655526 126440 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 10 1 4 7.0 CCCCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44344413 110056 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCCc1ccc(CCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL325193 110056 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCCc1ccc(CCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
44394273 64247 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 395 12 3 2 5.6 CCCCCCCCCc1ccc(CN[C@H]2CCC[C@H](P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL181597 64247 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 395 12 3 2 5.6 CCCCCCCCCc1ccc(CN[C@H]2CCC[C@H](P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
10126584 13484 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 14 3 3 4.7 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
CHEMBL119413 13484 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 14 3 3 4.7 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
9796603 163769 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 14 3 2 4.2 CCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL421234 163769 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 14 3 2 4.2 CCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
127037694 136132 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 347 13 1 3 4.7 CCCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3740062 136132 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 347 13 1 3 4.7 CCCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762318 126360 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655447 126360 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
44234761 125913 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 2 3 5.1 CCc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651722 125913 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 2 3 5.1 CCc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
11575787 70288 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL195014 70288 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
59762422 126392 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 3 7.0 CC(C)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
CHEMBL3655477 126392 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 3 7.0 CC(C)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
44394161 66690 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 2 2 6.1 CCCCCCCCCCCCCC1CCCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL187061 66690 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 2 2 6.1 CCCCCCCCCCCCCC1CCCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
59762398 126395 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 496 7 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccn1 nan
CHEMBL3655480 126395 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 496 7 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccn1 nan
44159394 126450 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655536 126450 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
11604577 71981 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL198415 71981 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
59762399 126348 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655435 126348 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
44233493 126451 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655537 126451 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10174548 12692 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 507 18 3 4 6.0 CCCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL118815 12692 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 507 18 3 4 6.0 CCCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
11271470 137059 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 8 1 4 6.1 CCc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL375488 137059 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 8 1 4 6.1 CCc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
10309462 13521 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 385 14 3 3 4.7 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
CHEMBL119440 13521 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 385 14 3 3 4.7 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
59762317 126358 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1cccnc1 nan
CHEMBL3655445 126358 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1cccnc1 nan
59762406 126378 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655464 126378 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
44233494 126452 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)OC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655538 126452 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)OC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
46885796 8326 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1093429 8326 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1 10.1016/j.bmcl.2010.02.098
44344270 109627 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 5 3.9 CCCCCCCc1nc(-c2ccc(CNCCCP(=O)(O)O)cc2)no1 10.1016/j.bmcl.2004.04.070
CHEMBL323617 109627 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 5 3.9 CCCCCCCc1nc(-c2ccc(CNCCCP(=O)(O)O)cc2)no1 10.1016/j.bmcl.2004.04.070
59762335 126353 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 531 9 1 5 5.8 COC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655440 126353 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 531 9 1 5 5.8 COC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
44413365 77029 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 467 6 2 5 5.8 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCC(F)(F)CC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208648 77029 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 467 6 2 5 5.8 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCC(F)(F)CC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
44344446 114323 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 17 3 2 5.4 CCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL334144 114323 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 17 3 2 5.4 CCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762347 126347 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NC(C)(C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655434 126347 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NC(C)(C)CO3)cc2n1Cc1ccccc1 nan
59762321 126362 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655449 126362 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
59762323 126382 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 536 8 1 5 6.9 CC(C)c1c(C(=O)NCc2ccc(C(F)(F)F)nc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655468 126382 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 536 8 1 5 6.9 CC(C)c1c(C(=O)NCc2ccc(C(F)(F)F)nc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
44413274 138182 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 6 2 4 5.7 O=C(O)C1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377968 138182 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 6 2 4 5.7 O=C(O)C1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
59762313 126367 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 8 1 5 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C=O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655453 126367 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 8 1 5 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C=O)n(Cc3ccccn3)c2c1 nan
59762322 126350 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655437 126350 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1ccccc1 nan
101863648 157941 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 303 10 1 2 4.1 CCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4090982 157941 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 303 10 1 2 4.1 CCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.6b01575
10149721 84673 4 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 317 11 1 2 4.5 CCCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/jm0492507
CHEMBL224623 84673 4 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 317 11 1 2 4.5 CCCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/jm0492507
25059488 125904 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651714 125904 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059488 125904 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651714 125904 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762293 126387 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccn1 nan
CHEMBL3655472 126387 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccn1 nan
59762353 126390 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655475 126390 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
44234256 126891 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 9 1 4 6.5 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659689 126891 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 9 1 4 6.5 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394279 66814 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 3 2 5.8 CCCCCCCCCCCCCC[C@H]1CC[C@H](CCP(=O)(O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187588 66814 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 3 2 5.8 CCCCCCCCCCCCCC[C@H]1CC[C@H](CCP(=O)(O)O)N1 10.1016/j.bmcl.2004.07.049
44591265 179401 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL474689 179401 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
44591266 178720 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL473269 178720 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
44591249 180054 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL475495 180054 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
44591250 189162 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL515921 189162 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
44565712 189221 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 10 4 5 4.0 Cc1ccccc1-c1ccc(CCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL516380 189221 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 10 4 5 4.0 Cc1ccccc1-c1ccc(CCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762319 126399 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 464 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccn1 nan
CHEMBL3655484 126399 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 464 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccn1 nan
59762282 126345 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 8 2 3 5.4 C#CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655432 126345 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 8 2 3 5.4 C#CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762349 126377 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3=O)cc2n1Cc1ccccc1 nan
CHEMBL3655463 126377 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3=O)cc2n1Cc1ccccc1 nan
59762413 126408 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 469 8 2 3 6.8 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655494 126408 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 469 8 2 3 6.8 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
72555272 126411 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.1 C=C(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655497 126411 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.1 C=C(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
44394211 66827 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 2 3 5.4 CCCCCCCCCCCCCCN1CCC(O)(P(C)(=O)O)CC1 10.1016/j.bmcl.2004.07.049
CHEMBL187645 66827 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 2 3 5.4 CCCCCCCCCCCCCCN1CCC(O)(P(C)(=O)O)CC1 10.1016/j.bmcl.2004.07.049
10271422 9844 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL114584 9844 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
127037696 136284 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 305 10 1 3 3.6 CCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3741496 136284 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 305 10 1 3 3.6 CCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762429 126419 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 508 8 1 7 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ncco1 nan
CHEMBL3655505 126419 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 508 8 1 7 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ncco1 nan
10127475 165476 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL425563 165476 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
10127475 165476 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
CHEMBL425563 165476 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
59762336 126421 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 439 6 2 5 5.0 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(O)cc32)no1 nan
CHEMBL3655507 126421 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 439 6 2 5 5.0 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(O)cc32)no1 nan
54582607 62130 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition of S1P3 receptorInhibition of S1P3 receptor
ChEMBL 375 3 2 3 5.8 Cc1cc(O)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 10.1016/j.bmcl.2011.04.097
CHEMBL1779895 62130 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition of S1P3 receptorInhibition of S1P3 receptor
ChEMBL 375 3 2 3 5.8 Cc1cc(O)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 10.1016/j.bmcl.2011.04.097
44344298 13433 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 6 3.0 CCCCCCCn1nnc(-c2ccc(CNCCCP(=O)(O)O)cc2)n1 10.1016/j.bmcl.2004.04.070
CHEMBL119382 13433 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 6 3.0 CCCCCCCn1nnc(-c2ccc(CNCCCP(=O)(O)O)cc2)n1 10.1016/j.bmcl.2004.04.070
59762414 126394 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655479 126394 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
44159276 126318 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 1 3 6.0 COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655405 126318 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 1 3 6.0 COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234002 126886 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659684 126886 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762364 126412 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 497 7 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3cncnc3)cc2n1Cc1ccccn1 nan
CHEMBL3655498 126412 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 497 7 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3cncnc3)cc2n1Cc1ccccn1 nan
10317453 70075 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 377 7 1 5 3.9 CCCc1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL194578 70075 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 377 7 1 5 3.9 CCCc1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
59762338 123898 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 7 1 5 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3nnco3)cc2n1Cc1ccccc1 nan
CHEMBL3639543 123898 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 7 1 5 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3nnco3)cc2n1Cc1ccccc1 nan
10150372 112409 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 3 3 4.4 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
CHEMBL331054 112409 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 3 3 4.4 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
44565739 178382 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL470511 178382 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
25059745 125905 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651715 125905 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059745 125905 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651715 125905 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25060000 126327 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccc1 nan
CHEMBL3655414 126327 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccc1 nan
44233020 126335 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccc1 nan
CHEMBL3655422 126335 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccc1 nan
24812110 10650 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 13 4 4 3.3 CCCCCCCCc1ccc(CCC(N)(CO)OP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL117130 10650 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 13 4 4 3.3 CCCCCCCCc1ccc(CCC(N)(CO)OP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
11452022 3539 33 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
6996 3539 33 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
CHEMBL366208 3539 33 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
2924 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
44398069 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
9908268 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
CHEMBL114606 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
2924 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
44398069 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
9908268 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
CHEMBL114606 1610 37 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
46905530 10195 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 14 5 6 2.6 CCCCCCCCc1ccc(CCC(N)(CO)CO[PH](O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL1161691 10195 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 14 5 6 2.6 CCCCCCCCc1ccc(CCC(N)(CO)CO[PH](O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
25059749 126325 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 10 1 4 6.0 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655412 126325 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 10 1 4 6.0 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10173327 10949 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 421 15 3 4 4.7 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117715 10949 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 421 15 3 4 4.7 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
9885762 9642 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CCC(N)CC(O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL113344 9642 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CCC(N)CC(O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
11690779 189123 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 442 8 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL515603 189123 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 442 8 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762379 126365 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655451 126365 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN(C)C)n(Cc3ccccn3)c2c1 nan
25060264 126431 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.2 CC(C)NC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655517 126431 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.2 CC(C)NC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762294 126388 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 435 6 2 4 5.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1cccnc1 nan
CHEMBL3655473 126388 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 435 6 2 4 5.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1cccnc1 nan
10125714 110028 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 319 13 2 2 4.7 CCCCCCCCc1ccc(CCC(N)CCC(=O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL325050 110028 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 319 13 2 2 4.7 CCCCCCCCc1ccc(CCC(N)CCC(=O)O)cc1 10.1016/j.bmcl.2004.02.106
59762300 126409 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 8 2 4 6.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655495 126409 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 8 2 4 6.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccn1 nan
44412415 77813 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 419 8 2 5 5.3 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](CCC(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
CHEMBL210468 77813 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 419 8 2 5 5.3 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](CCC(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
44233747 126883 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 603 8 1 5 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCN(C(=O)OC(C)(C)C)C3)cc2n1Cc1ccccc1 nan
CHEMBL3659681 126883 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 603 8 1 5 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCN(C(=O)OC(C)(C)C)C3)cc2n1Cc1ccccc1 nan
10172545 9534 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.4 CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL112655 9534 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.4 CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
59762315 126368 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 465 8 2 5 4.6 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CO)n(Cc3ccccn3)c2c1 nan
CHEMBL3655454 126368 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 465 8 2 5 4.6 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CO)n(Cc3ccccn3)c2c1 nan
59762403 126342 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655429 126342 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44413349 77286 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208838 77286 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
10271422 9844 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranesDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL114584 9844 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranesDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
25060002 126336 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655423 126336 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
69228911 126356 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
CHEMBL3655443 126356 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
59762358 126396 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655481 126396 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCC3)cc2n1Cc1cccnc1 nan
44394212 66834 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187692 66834 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
59762417 126405 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 483 8 2 3 7.2 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655491 126405 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 483 8 2 3 7.2 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59762438 126406 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655492 126406 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
46885797 7948 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1C(F)(F)F 10.1016/j.bmcl.2010.02.098
CHEMBL1090828 7948 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1C(F)(F)F 10.1016/j.bmcl.2010.02.098
44341399 205239 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 724 25 7 5 7.9 CCCCCCCCc1ccc(CCC(N)/C=C/P(=O)(O)O)cc1.CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL91283 205239 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 724 25 7 5 7.9 CCCCCCCCc1ccc(CCC(N)/C=C/P(=O)(O)O)cc1.CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
10126736 109999 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 16 3 4 4.5 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OCC 10.1016/j.bmcl.2004.04.070
CHEMBL324820 109999 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 16 3 4 4.5 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OCC 10.1016/j.bmcl.2004.04.070
10288527 84605 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.8 Cc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL224005 84605 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.8 Cc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
44412353 165675 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 435 6 2 5 5.5 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCC5)c(F)c4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL426688 165675 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 435 6 2 5 5.5 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCC5)c(F)c4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
59762425 126398 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 533 9 1 4 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C[N+]3(C)CCCC3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655483 126398 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 533 9 1 4 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C[N+]3(C)CCCC3)n(Cc3ccccn3)c2c1 nan
10309022 9942 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 2 3 4.1 CCCCCCCCc1ccc(CCC(N)CCS(=O)(=O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115131 9942 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 2 3 4.1 CCCCCCCCc1ccc(CCC(N)CCS(=O)(=O)O)cc1 10.1016/j.bmcl.2004.02.106
59762374 126354 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1cccnc1 nan
CHEMBL3655441 126354 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1cccnc1 nan
44412165 77408 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 77408 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
162650548 179551 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 366 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
CHEMBL4748743 179551 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 366 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
44234259 126892 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 10 1 4 6.6 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659690 126892 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 10 1 4 6.6 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394212 66834 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187692 66834 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
10172354 113287 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 357 14 3 3 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL332373 113287 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 357 14 3 3 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
44159278 126328 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 5 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3=O)cc2n1Cc1ccccc1 nan
CHEMBL3655415 126328 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 5 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3=O)cc2n1Cc1ccccc1 nan
9824415 110067 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 437 13 3 4 4.1 CCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL325247 110067 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 437 13 3 4 4.1 CCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10174181 11164 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 479 16 3 4 5.2 CCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117910 11164 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 479 16 3 4 5.2 CCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10384596 10041 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115713 10041 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44233257 126444 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 5 5.9 CC(C)c1c(C(=O)NCc2cccnc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655530 126444 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 5 5.9 CC(C)c1c(C(=O)NCc2cccnc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
59762412 126402 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N(C)C3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655488 126402 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N(C)C3CCCC3)cc2n1Cc1ccccc1 nan
59762389 126427 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 6 4.9 COC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655512 126427 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 6 4.9 COC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
59762299 126341 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 8 1 6 4.8 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655428 126341 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 8 1 6 4.8 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44159393 126443 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 10 1 4 7.0 CC(C)CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655529 126443 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 10 1 4 7.0 CC(C)CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762286 126376 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.6 CC(C)C(=O)Nc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655462 126376 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.6 CC(C)C(=O)Nc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762434 126379 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 9 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ncco3)cc2n1Cc1ccccc1 nan
CHEMBL3655465 126379 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 9 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ncco3)cc2n1Cc1ccccc1 nan
44233255 126441 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccn1 nan
CHEMBL3655527 126441 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccn1 nan
44233256 126445 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 454 8 1 4 5.9 CCOC(=O)c1ccc2c(C(=O)NCc3ccccc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655531 126445 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 454 8 1 4 5.9 CCOC(=O)c1ccc2c(C(=O)NCc3ccccc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44394116 66018 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 349 17 2 2 5.2 CCCCCCCCCCCCCCN(C)CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185100 66018 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 349 17 2 2 5.2 CCCCCCCCCCCCCCN(C)CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44234511 126894 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/N(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3659692 126894 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/N(C)C)cc2n1Cc1ccccn1 nan
10289318 113528 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 513 14 3 3 5.6 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
CHEMBL332667 113528 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 513 14 3 3 5.6 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
10287343 12213 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 387 15 3 4 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL118508 12213 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 387 15 3 4 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
44159279 126435 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655521 126435 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN(C)C)cc2n1Cc1ccccc1 nan
59495631 156711 0 None -1318 2 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 430 8 1 6 5.0 COCc1cc(-c2nc(-c3cccc(OCC(=O)O)c3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
CHEMBL4076530 156711 0 None -1318 2 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 430 8 1 6 5.0 COCc1cc(-c2nc(-c3cccc(OCC(=O)O)c3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
137644547 157495 0 None -758 2 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 494 7 1 5 7.0 COCc1cc(-c2nc(-c3ccc(-c4ccc(C(=O)O)c(F)c4)cc3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
CHEMBL4085783 157495 0 None -758 2 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 494 7 1 5 7.0 COCc1cc(-c2nc(-c3ccc(-c4ccc(C(=O)O)c(F)c4)cc3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
11545181 3952 4 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
2930 3952 4 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
CHEMBL389033 3952 4 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
44342175 85095 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227371 85095 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL422074 85095 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
57699087 103122 0 None -19 2 Human 5.3 pKi = 5.3 Binding
Inhibition of S1P3 receptor (unknown origin)Inhibition of S1P3 receptor (unknown origin)
ChEMBL 362 6 1 6 2.1 CCn1c(OC)nnc1[C@@H](C)NS(=O)(=O)c1ccc(F)c(Cl)c1 10.1016/j.bmcl.2013.09.058
CHEMBL3086532 103122 0 None -19 2 Human 5.3 pKi = 5.3 Binding
Inhibition of S1P3 receptor (unknown origin)Inhibition of S1P3 receptor (unknown origin)
ChEMBL 362 6 1 6 2.1 CCn1c(OC)nnc1[C@@H](C)NS(=O)(=O)c1ccc(F)c(Cl)c1 10.1016/j.bmcl.2013.09.058
11363176 3100 42 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
5446 3100 42 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
9320 3100 42 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
CHEMBL1096146 3100 42 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
10883396 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
10883396 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
10883396 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
5283560 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
5283560 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
5283560 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
911 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
911 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
911 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
CHEMBL225155 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
CHEMBL225155 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
CHEMBL225155 3592 39 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
11588811 3949 39 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
136212600 3949 39 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
3324 3949 39 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
CHEMBL228102 3949 39 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
11545181 3952 4 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
2930 3952 4 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
CHEMBL389033 3952 4 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
10310 3826 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
16046248 3826 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
CHEMBL4303550 3826 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
6992 3946 0 None -23 5 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 369 11 3 3 4.3 CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O 21632869
73755254 3946 0 None -23 5 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 369 11 3 3 4.3 CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O 21632869